escherichia coli infections/drug therapy	anti-bacterial agents/adverse effects	0.010752688172043012	34107499
immune system diseases/drug therapy	IL6	0.021505376344086023	36159840
protective agents/pharmacology	PDCD1	0.2688172043010753	33506015
immune system diseases/drug therapy	LIF	0.010752688172043012	36159840
immune system diseases/drug therapy	PDCD1	0.2688172043010753	36159840
neoplasms	immune checkpoint inhibitors	0.38795986622073575	35842365
neoplasms	immune checkpoint inhibitors	0.38795986622073575	32584703
neoplasms	infliximab/adverse effects	0.1637508198518016	32584703
adrenal cortex hormones/therapeutic use	SNCA	0.09467811291093199	32641348
neoplasms	colitis	0.1637508198518016	35842365
adrenal cortex hormones/therapeutic use	TNF	0.09467811291093199	32641348
interleukin-17/genetics	micrornas/genetics	0.010752688172043012	33462141
colitis ulcerative	immune checkpoint inhibitors	0.3225806451612903	33146440
neoplasms	recurrence	0.04301075268817204	35842365
neoplasms	diarrhea/chemically induced	0.4853981611344865	32584703
interleukin-17/genetics	gene expression regulation neoplastic	0.010752688172043012	33462141
interleukin-17/genetics	lymphocytes tumor-infiltrating/metabolism	0.010752688172043012	33462141
diarrhea	neoplasms	0.08461898083216456	35842365
neoplasms	colitis/chemically induced	0.7267635590216236	36389768
neoplasms	colitis/chemically induced	0.7267635590216236	36189293
neoplasms	colitis/chemically induced	0.7267635590216236	32584703
colitis/therapy	immune checkpoint inhibitors	0.3225806451612903	33566423
interleukin-17/genetics	t-lymphocytes cytotoxic/immunology	0.010752688172043012	33462141
interleukin-17/genetics	tumor microenvironment/drug effects	0.010752688172043012	33462141
diarrhea	immune checkpoint inhibitors	0.10168302945301544	35842365
diarrhea	immune checkpoint inhibitors	0.10168302945301544	32780983
drug-related side effects and adverse reactions/prevention & control	growth inhibitors/therapeutic use	0.010752688172043012	34987517
neoplasms	inflammatory bowel diseases	0.08461898083216456	35842365
interleukin-17/genetics	immune checkpoint inhibitors/administration & dosage	0.04301075268817205	33462141
interleukin-17/genetics	ht29 cells	0.010752688172043012	33462141
diarrhea	colitis	0.001402524544179523	35842365
diarrhea	colitis	0.001402524544179523	32780983
colitis/therapy	immunologic factors	0.021505376344086023	33566423
interleukin-17/genetics	colitis/chemically induced	0.7419354838709677	33462141
diarrhea	recurrence	0.021505376344086023	35842365
interleukin-17/genetics	colorectal neoplasms/drug therapy	0.010752688172043012	33462141
drug-related side effects and adverse reactions/prevention & control	phosphatidylinositol 3-kinases/metabolism	0.010752688172043012	34987517
drug-related side effects and adverse reactions/prevention & control	antineoplastic agents immunological/therapeutic use	0.03225806451612904	34987517
interleukin-17/genetics	b7-h1 antigen/genetics	0.010752688172043012	33462141
drug-related side effects and adverse reactions/prevention & control	lymphocytes tumor-infiltrating/immunology	0.010752688172043012	34987517
drug-related side effects and adverse reactions/prevention & control	colitis/etiology	0.021505376344086023	34987517
drug-related side effects and adverse reactions/prevention & control	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	34987517
drug-related side effects and adverse reactions/prevention & control	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	34987517
diarrhea	inflammatory bowel diseases	0.04277699859747545	35842365
intestinal mucosa/diagnostic imaging	colon/diagnostic imaging	0.010752688172043012	32414860
drug-related side effects and adverse reactions/prevention & control	cell line tumor	0.021505376344086023	34987517
intestinal mucosa/diagnostic imaging	drug resistance/immunology	0.010752688172043012	32414860
intestinal mucosa/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5698924731182795	32414860
drug-related side effects and adverse reactions/prevention & control	cd8-positive t-lymphocytes/immunology	0.010752688172043012	34987517
neoplasms	LTF	0.04301075268817204	32584703
intestinal mucosa/diagnostic imaging	skin neoplasms/drug therapy	0.021505376344086023	32414860
intestinal mucosa/diagnostic imaging	infliximab/adverse effects	0.04301075268817205	32414860
nephritis/chemically induced	nivolumab/therapeutic use	0.021505376344086023	32130969
drug-related side effects and adverse reactions/prevention & control	cytotoxicity immunologic	0.010752688172043012	34987517
interleukin-17/genetics	APC	0.021505376344086023	33462141
drug-related side effects and adverse reactions/prevention & control	CD8A	0.05376344086021506	34987517
interleukin-17/genetics	CD274	0.16129032258064516	33462141
carcinoma renal cell/drug therapy	nephritis/chemically induced	0.021505376344086023	32130969
intestinal mucosa/diagnostic imaging	colitis/chemically induced	0.7419354838709677	32414860
nephritis/chemically induced	diabetes mellitus type 1/chemically induced	0.010752688172043012	32130969
interleukin-17/genetics	CD8A	0.05376344086021506	33462141
carcinoma renal cell/drug therapy	nivolumab/therapeutic use	0.04277699859747545	32130969
intestinal mucosa/diagnostic imaging	glucocorticoids/pharmacology	0.010752688172043012	32414860
interleukin-17/genetics	IL17A	0.021505376344086023	33462141
drug-related side effects and adverse reactions/prevention & control	MTOR	0.010752688172043012	34987517
nephritis/chemically induced	exanthema/chemically induced	0.010752688172043012	32130969
nephritis/chemically induced	bevacizumab/administration & dosage	0.010752688172043012	32130969
carcinoma renal cell/drug therapy	diabetes mellitus type 1/chemically induced	0.021505376344086023	32130969
drug-related side effects and adverse reactions/prevention & control	PDCD1	0.2688172043010753	34987517
intestinal mucosa/diagnostic imaging	melanoma/drug therapy	0.05376344086021506	32414860
interleukin-17/genetics	MIR15B	0.010752688172043012	33462141
interleukin-17/genetics	NRF1	0.010752688172043012	33462141
carcinoma renal cell/drug therapy	immune checkpoint inhibitors/adverse effects	0.8176718092566619	35277350
nephritis/chemically induced	pneumonia/chemically induced	0.03225806451612904	32130969
interleukin-17/genetics	PDCD1	0.2688172043010753	33462141
carcinoma renal cell/drug therapy	exanthema/chemically induced	0.021505376344086023	32130969
carcinoma renal cell/drug therapy	bevacizumab/administration & dosage	0.021505376344086023	32130969
nephritis/chemically induced	fatigue/chemically induced	0.010752688172043012	32130969
intestinal mucosa/diagnostic imaging	immunosuppressive agents/pharmacology	0.010752688172043012	32414860
carcinoma renal cell/drug therapy	pneumonia/chemically induced	0.0638148667601683	32130969
carcinoma renal cell/drug therapy	fatigue/chemically induced	0.021505376344086023	32130969
intestinal mucosa/diagnostic imaging	mucositis/chemically induced	0.010752688172043012	32414860
nivolumab/adverse effects	pyrimidines/therapeutic use	0.2426367461430575	33096100
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.14957366220908094	34159488
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.14957366220908094	33096100
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.14957366220908094	33882697
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.14957366220908094	33906378
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.14957366220908094	34332139
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.14957366220908094	31595568
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.14957366220908094	32931028
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.14957366220908094	32028372
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.14957366220908094	33476895
nephritis/chemically induced	pruritus/chemically induced	0.010752688172043012	32130969
carcinoma renal cell/drug therapy	pruritus/chemically induced	0.021505376344086023	32130969
nivolumab/therapeutic use	diabetes mellitus type 1/chemically induced	0.021505376344086023	32130969
nivolumab/adverse effects	pneumonia/chemically induced	0.34250882357474227	35124713
carcinoma renal cell/drug therapy	adrenal insufficiency/chemically induced	0.021505376344086023	32130969
adrenal gland diseases/diagnostic imaging	myocarditis/diagnostic imaging	0.010752688172043012	33375984
nivolumab/adverse effects	colitis/diagnosis	0.2426367461430575	32028372
nephritis/chemically induced	adrenal insufficiency/chemically induced	0.010752688172043012	32130969
adrenal gland diseases/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5698924731182795	33375984
carcinoma renal cell/drug therapy	axitinib/administration & dosage	0.021505376344086023	32130969
nivolumab/therapeutic use	exanthema/chemically induced	0.021505376344086023	32130969
nivolumab/therapeutic use	bevacizumab/administration & dosage	0.021505376344086023	32130969
carcinoma renal cell/drug therapy	inflammatory bowel diseases/drug therapy	0.0638148667601683	35277350
nivolumab/adverse effects	immune checkpoint inhibitors	0.8157915303073194	35191192
nivolumab/adverse effects	immune checkpoint inhibitors	0.8157915303073194	34716545
nivolumab/adverse effects	immune checkpoint inhibitors	0.8157915303073194	35124713
nephritis/chemically induced	axitinib/administration & dosage	0.010752688172043012	32130969
nivolumab/therapeutic use	arthritis/chemically induced	0.021505376344086023	36096534
adrenal gland diseases/diagnostic imaging	pancreatitis/diagnostic imaging	0.010752688172043012	33375984
nivolumab/therapeutic use	pneumonia/chemically induced	0.0638148667601683	32130969
carcinoma renal cell/drug therapy	proton pump inhibitors/adverse effects	0.021505376344086023	35277350
adrenal gland diseases/diagnostic imaging	neoplasms/diagnostic imaging	0.021505376344086023	33375984
nivolumab/therapeutic use	fatigue/chemically induced	0.021505376344086023	32130969
nivolumab/adverse effects	lung neoplasms/drug therapy	0.2426367461430575	34716545
carcinoma renal cell/drug therapy	colitis/chemically induced	0.5483870967741937	32130969
carcinoma renal cell/drug therapy	colitis/chemically induced	0.5483870967741937	35277350
carcinoma renal cell/drug therapy	hypophysitis/chemically induced	0.021505376344086023	32130969
nivolumab/therapeutic use	immune checkpoint inhibitors	0.5434782608695652	36096534
nivolumab/adverse effects	protein kinase inhibitors/therapeutic use	0.12903225806451613	33096100
carcinoma renal cell/drug therapy	angiogenesis inhibitors/therapeutic use	0.021505376344086023	32130969
nivolumab/adverse effects	squamous cell carcinoma of head and neck/drug therapy	0.12903225806451613	33476895
nivolumab/therapeutic use	glucocorticoids	0.021505376344086023	36096534
nivolumab/adverse effects	tongue neoplasms/drug therapy	0.12903225806451613	33476895
nivolumab/adverse effects	carcinoma non-small-cell lung/drug therapy	0.2426367461430575	35124713
nephritis/chemically induced	colitis/chemically induced	0.7419354838709677	32130969
nivolumab/therapeutic use	pruritus/chemically induced	0.021505376344086023	32130969
melanoma/genetics	receptors cxcr6/genetics	0.010752688172043012	32603654
carcinoma renal cell/drug therapy	myocarditis/chemically induced	0.021505376344086023	32130969
nephritis/chemically induced	hypophysitis/chemically induced	0.010752688172043012	32130969
adrenal gland diseases/diagnostic imaging	sarcoidosis/diagnostic imaging	0.010752688172043012	33375984
melanoma/genetics	gene expression regulation/genetics	0.010752688172043012	32603654
melanoma/genetics	receptors cxcr3/genetics	0.010752688172043012	32603654
carcinoma renal cell/drug therapy	hepatitis autoimmune/etiology	0.021505376344086023	32130969
nephritis/chemically induced	angiogenesis inhibitors/therapeutic use	0.010752688172043012	32130969
nivolumab/adverse effects	neoplasms/drug therapy	0.8302262549622297	33096100
adrenal gland diseases/diagnostic imaging	hepatitis/diagnostic imaging	0.010752688172043012	33375984
melanoma/genetics	cd8-positive t-lymphocytes/cytology	0.010752688172043012	32603654
nivolumab/therapeutic use	adrenal insufficiency/chemically induced	0.021505376344086023	32130969
carcinoma renal cell/drug therapy	myasthenia gravis/chemically induced	0.021505376344086023	32130969
melanoma/genetics	inflammation/drug therapy	0.021505376344086023	32603654
carcinoma renal cell/drug therapy	immune checkpoint inhibitors/therapeutic use	0.04277699859747545	32130969
nivolumab/adverse effects	diarrhea/chemically induced	0.8770712327596885	31595568
melanoma/genetics	immune checkpoint inhibitors/adverse effects	0.5698924731182795	32603654
nivolumab/therapeutic use	axitinib/administration & dosage	0.021505376344086023	32130969
nephritis/chemically induced	myocarditis/chemically induced	0.010752688172043012	32130969
melanoma/genetics	myeloid cells/cytology	0.010752688172043012	32603654
nivolumab/adverse effects	ipilimumab/adverse effects	2.7098127426765173e-06	34159488
nivolumab/adverse effects	ipilimumab/adverse effects	2.7098127426765173e-06	33096100
nivolumab/adverse effects	ipilimumab/adverse effects	2.7098127426765173e-06	33882697
nivolumab/adverse effects	ipilimumab/adverse effects	2.7098127426765173e-06	34332139
nivolumab/adverse effects	ipilimumab/adverse effects	2.7098127426765173e-06	31595568
nivolumab/adverse effects	ipilimumab/adverse effects	2.7098127426765173e-06	32931028
nivolumab/adverse effects	ipilimumab/adverse effects	2.7098127426765173e-06	35191192
melanoma/genetics	ctla-4 antigen/immunology	0.010752688172043012	32603654
adrenal gland diseases/diagnostic imaging	pericarditis/diagnostic imaging	0.010752688172043012	33375984
nivolumab/adverse effects	colitis/chemically induced	0.3515184224404146	34159488
nivolumab/adverse effects	colitis/chemically induced	0.3515184224404146	34716545
nivolumab/adverse effects	colitis/chemically induced	0.3515184224404146	33096100
nivolumab/adverse effects	colitis/chemically induced	0.3515184224404146	35124713
nivolumab/adverse effects	colitis/chemically induced	0.3515184224404146	33906378
nivolumab/adverse effects	colitis/chemically induced	0.3515184224404146	34332139
nivolumab/adverse effects	colitis/chemically induced	0.3515184224404146	33882697
nivolumab/adverse effects	colitis/chemically induced	0.3515184224404146	31595568
nivolumab/adverse effects	colitis/chemically induced	0.3515184224404146	32931028
nivolumab/adverse effects	colitis/chemically induced	0.3515184224404146	35191192
nephritis/chemically induced	hepatitis autoimmune/etiology	0.010752688172043012	32130969
adrenal gland diseases/diagnostic imaging	encephalitis/diagnostic imaging	0.010752688172043012	33375984
nivolumab/therapeutic use	diarrhea/chemically induced	0.27980364656381496	36096534
carcinoma renal cell/drug therapy	ipilimumab/therapeutic use	0.0007012622720897616	32130969
carcinoma renal cell/drug therapy	ipilimumab/therapeutic use	0.0007012622720897616	35277350
nivolumab/adverse effects	paclitaxel/therapeutic use	0.12903225806451613	33476895
nephritis/chemically induced	myasthenia gravis/chemically induced	0.010752688172043012	32130969
nivolumab/therapeutic use	colitis/chemically induced	0.5483870967741937	32130969
nivolumab/therapeutic use	colitis/chemically induced	0.5483870967741937	36096534
nephritis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
nivolumab/adverse effects	oropharyngeal neoplasms/drug therapy	0.12903225806451613	33906378
nivolumab/therapeutic use	hypophysitis/chemically induced	0.021505376344086023	32130969
adrenal gland diseases/diagnostic imaging	colitis/diagnostic imaging	0.010752688172043012	33375984
melanoma/genetics	colitis/drug therapy	0.03225806451612904	32603654
nivolumab/therapeutic use	angiogenesis inhibitors/therapeutic use	0.021505376344086023	32130969
nivolumab/adverse effects	disease susceptibility	0.12903225806451613	32028372
nivolumab/adverse effects	colitis ulcerative/chemically induced	0.12903225806451613	33476895
nivolumab/adverse effects	melanoma/drug therapy	0.5070047433695257	33882697
nivolumab/therapeutic use	myocarditis/chemically induced	0.021505376344086023	32130969
nivolumab/adverse effects	piperidines/therapeutic use	0.2426367461430575	33096100
melanoma/genetics	receptors antigen t-cell/genetics	0.010752688172043012	32603654
nivolumab/adverse effects	drug-related side effects and adverse reactions/diagnosis	0.12903225806451613	35191192
nephritis/chemically induced	ipilimumab/therapeutic use	0.03225806451612904	32130969
prednisolone/therapeutic use	nivolumab/adverse effects	0.12903225806451613	34716545
melanoma/genetics	t-lymphocytes regulatory/cytology	0.010752688172043012	32603654
nivolumab/therapeutic use	hepatitis autoimmune/etiology	0.021505376344086023	32130969
nivolumab/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.6841732290121534	33476895
nivolumab/adverse effects	postoperative complications	0.12903225806451613	32028372
nivolumab/therapeutic use	myasthenia gravis/chemically induced	0.021505376344086023	32130969
nivolumab/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.04277699859747545	32130969
melanoma/genetics	chemokines/metabolism	0.010752688172043012	32603654
melanoma/genetics	multigene family	0.010752688172043012	32603654
nivolumab/adverse effects	antineoplastic agents immunological/adverse effects	0.6329580769600702	33476895
nivolumab/adverse effects	ipilimumab/therapeutic use	0.34250882357474227	35124713
adrenal gland diseases/diagnostic imaging	pneumonia/diagnostic imaging	0.010752688172043012	33375984
prednisolone/therapeutic use	immune checkpoint inhibitors	0.3225806451612903	34716545
nivolumab/therapeutic use	ipilimumab/therapeutic use	0.0638148667601683	32130969
prednisolone/therapeutic use	lung neoplasms/drug therapy	0.021505376344086023	34716545
melanoma/genetics	CTLA4	0.12903225806451613	32603654
hashimoto disease/chemically induced	nivolumab/adverse effects	0.12903225806451613	33476895
nivolumab/adverse effects	CTLA4	0.8302262549622297	35191192
melanoma/genetics	PDCD1	0.2688172043010753	32603654
nivolumab/therapeutic use	CHI3L1	0.021505376344086023	36096534
nivolumab/therapeutic use	CXCL8	0.021505376344086023	36096534
hashimoto disease/chemically induced	immune checkpoint inhibitors/adverse effects	0.5698924731182795	33476895
nivolumab/therapeutic use	IL17A	0.04277699859747545	36096534
nivolumab/adverse effects	PDCD1	0.8905168434096232	35191192
nivolumab/adverse effects	PDCD1	0.8905168434096232	33906378
nivolumab/adverse effects	SNCA	0.34250882357474227	33476895
nivolumab/therapeutic use	IL6	0.04277699859747545	36096534
gene expression regulation/genetics	receptors cxcr3/genetics	0.010752688172043012	32603654
host microbial interactions/drug effects	metabolome/drug effects	0.010752688172043012	34162429
prednisolone/therapeutic use	colitis/chemically induced	0.7419354838709677	34716545
gene expression regulation/genetics	cd8-positive t-lymphocytes/cytology	0.010752688172043012	32603654
host microbial interactions/drug effects	immune checkpoint inhibitors/adverse effects	0.5698924731182795	34162429
gene expression regulation/genetics	inflammation/drug therapy	0.021505376344086023	32603654
sirolimus/therapeutic use	drug-related side effects and adverse reactions/prevention & control	0.010752688172043012	34987517
gene expression regulation/genetics	immune checkpoint inhibitors/adverse effects	0.5698924731182795	32603654
gene expression regulation/genetics	myeloid cells/cytology	0.010752688172043012	32603654
gene expression regulation/genetics	ctla-4 antigen/immunology	0.010752688172043012	32603654
hashimoto disease/chemically induced	squamous cell carcinoma of head and neck/drug therapy	0.010752688172043012	33476895
hashimoto disease/chemically induced	tongue neoplasms/drug therapy	0.010752688172043012	33476895
myeloid-derived suppressor cells/metabolism	azoxymethane/adverse effects	0.010752688172043012	33495297
host microbial interactions/drug effects	dysbiosis/etiology	0.010752688172043012	34162429
host microbial interactions/drug effects	neoplasms/complications	0.03225806451612904	34162429
gene expression regulation/genetics	colitis/drug therapy	0.03225806451612904	32603654
hashimoto disease/chemically induced	paclitaxel/therapeutic use	0.010752688172043012	33476895
myeloid-derived suppressor cells/metabolism	immune checkpoint inhibitors/administration & dosage	0.04301075268817205	33495297
myeloid-derived suppressor cells/metabolism	colitis/chemically induced	0.7419354838709677	33495297
myeloid-derived suppressor cells/metabolism	phthalazines/administration & dosage	0.010752688172043012	33495297
hashimoto disease/chemically induced	colitis ulcerative/chemically induced	0.010752688172043012	33476895
myeloid-derived suppressor cells/metabolism	dextran sulfate/adverse effects	0.010752688172043012	33495297
host microbial interactions/drug effects	colitis/etiology	0.021505376344086023	34162429
sirolimus/therapeutic use	growth inhibitors/therapeutic use	0.010752688172043012	34987517
gene expression regulation/genetics	receptors antigen t-cell/genetics	0.010752688172043012	32603654
myeloid-derived suppressor cells/metabolism	colonic neoplasms/drug therapy	0.010752688172043012	33495297
hashimoto disease/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	33476895
gene expression regulation/genetics	t-lymphocytes regulatory/cytology	0.010752688172043012	32603654
host microbial interactions/drug effects	antineoplastic agents immunological/adverse effects	0.07526881720430108	34162429
host microbial interactions/drug effects	anti-bacterial agents/pharmacology	0.010752688172043012	34162429
sirolimus/therapeutic use	phosphatidylinositol 3-kinases/metabolism	0.010752688172043012	34987517
sirolimus/therapeutic use	antineoplastic agents immunological/therapeutic use	0.03225806451612904	34987517
hashimoto disease/chemically induced	antineoplastic agents immunological/adverse effects	0.07526881720430108	33476895
myeloid-derived suppressor cells/metabolism	cell line tumor	0.021505376344086023	33495297
sirolimus/therapeutic use	lymphocytes tumor-infiltrating/immunology	0.010752688172043012	34987517
myeloid-derived suppressor cells/metabolism	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010752688172043012	33495297
sirolimus/therapeutic use	colitis/etiology	0.021505376344086023	34987517
gene expression regulation/genetics	chemokines/metabolism	0.010752688172043012	32603654
sirolimus/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	34987517
sirolimus/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	34987517
gene expression regulation/genetics	multigene family	0.010752688172043012	32603654
sirolimus/therapeutic use	cell line tumor	0.021505376344086023	34987517
myeloid-derived suppressor cells/metabolism	piperazines/administration & dosage	0.010752688172043012	33495297
sirolimus/therapeutic use	cd8-positive t-lymphocytes/immunology	0.010752688172043012	34987517
myeloid-derived suppressor cells/metabolism	APC	0.021505376344086023	33495297
myeloid-derived suppressor cells/metabolism	ARG1	0.010752688172043012	33495297
hashimoto disease/chemically induced	SNCA	0.03225806451612904	33476895
sirolimus/therapeutic use	cytotoxicity immunologic	0.010752688172043012	34987517
gene expression regulation/genetics	CTLA4	0.12903225806451613	32603654
myeloid-derived suppressor cells/metabolism	PARP1	0.010752688172043012	33495297
myeloid-derived suppressor cells/metabolism	PDCD1	0.2688172043010753	33495297
sirolimus/therapeutic use	CD8A	0.05376344086021506	34987517
myeloid-derived suppressor cells/metabolism	TIPARP	0.010752688172043012	33495297
glucocorticoids/therapeutic use	immune checkpoint inhibitors/adverse effects	0.5698924731182795	36377339
carcinoma non-small-cell lung	immune checkpoint inhibitors	0.3225806451612903	34106395
esophagitis	ulcer/chemically induced	0.010752688172043012	33746162
gene expression regulation/genetics	PDCD1	0.2688172043010753	32603654
sirolimus/therapeutic use	MTOR	0.010752688172043012	34987517
sirolimus/therapeutic use	PDCD1	0.2688172043010753	34987517
glucocorticoids/therapeutic use	disease progression	0.010752688172043012	36377339
esophagitis	immune checkpoint inhibitors	0.3225806451612903	33746162
colitis ulcerative/immunology	pyrimidines/therapeutic use	0.04277699859747545	34147519
psoriasis	immune checkpoint inhibitors	0.3225806451612903	35977003
ulcer/chemically induced	immune checkpoint inhibitors	0.3225806451612903	33746162
colitis ulcerative/immunology	immune checkpoint inhibitors/adverse effects	0.3221131369798972	34338882
colitis ulcerative/immunology	immune checkpoint inhibitors/adverse effects	0.3221131369798972	34147519
glucocorticoids/therapeutic use	neoplasms/drug therapy	0.12903225806451613	36377339
glucocorticoids/therapeutic use	diarrhea/chemically induced	0.15053763440860218	36377339
colitis ulcerative/immunology	macrophages/drug effects	0.021505376344086023	34338882
carcinoma non-small-cell lung	colitis/chemically induced	0.7419354838709677	34106395
colitis ulcerative/immunology	interferon-gamma/metabolism	0.021505376344086023	34147519
colitis ulcerative/immunology	immunologic memory/drug effects	0.021505376344086023	34147519
glucocorticoids/therapeutic use	colitis/chemically induced	0.7419354838709677	36377339
colitis ulcerative/immunology	colon/drug effects	0.0007012622720897616	34338882
colitis ulcerative/immunology	colon/drug effects	0.0007012622720897616	34147519
glucocorticoids/therapeutic use	abdominal pain/chemically induced	0.010752688172043012	36377339
esophagitis	colitis/chemically induced	0.7419354838709677	33746162
ulcer/chemically induced	colitis/chemically induced	0.7419354838709677	33746162
psoriasis	colitis/chemically induced	0.7419354838709677	35977003
glucocorticoids/therapeutic use	antineoplastic agents immunological/therapeutic use	0.03225806451612904	36377339
psoriasis	dermatitis	0.010752688172043012	35977003
colitis ulcerative/immunology	crohn disease/immunology	0.021505376344086023	34338882
carcinoma non-small-cell lung	cd8-positive t-lymphocytes	0.010752688172043012	34106395
glucocorticoids/therapeutic use	gastritis/complications	0.010752688172043012	36377339
glucocorticoids/therapeutic use	enterocolitis/chemically induced	0.021505376344086023	36377339
colitis ulcerative/immunology	piperidines/therapeutic use	0.04277699859747545	34147519
colitis ulcerative/immunology	programmed cell death 1 receptor/antagonists & inhibitors	0.16549789621318373	34147519
colitis ulcerative/immunology	ctla-4 antigen/antagonists & inhibitors	0.0638148667601683	34147519
thyroiditis/diagnostic imaging	adrenal gland diseases/diagnostic imaging	0.010752688172043012	33375984
colitis ulcerative/immunology	graft vs host disease/immunology	0.021505376344086023	34338882
psoriasis	rna	0.010752688172043012	35977003
thyroiditis/diagnostic imaging	myocarditis/diagnostic imaging	0.010752688172043012	33375984
thyroiditis/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5698924731182795	33375984
colitis ulcerative/immunology	cd8-positive t-lymphocytes/drug effects	0.00023375409069658717	34338882
colitis ulcerative/immunology	cd8-positive t-lymphocytes/drug effects	0.00023375409069658717	34147519
colitis ulcerative/immunology	phenotype	0.00023375409069658717	34338882
colitis ulcerative/immunology	phenotype	0.00023375409069658717	34147519
escherichia coli infections/drug therapy	virus diseases/etiology	0.010752688172043012	34107499
thyroiditis/diagnostic imaging	pancreatitis/diagnostic imaging	0.010752688172043012	33375984
thyroiditis/diagnostic imaging	neoplasms/diagnostic imaging	0.021505376344086023	33375984
escherichia coli infections/drug therapy	immune checkpoint inhibitors/adverse effects	0.5698924731182795	34107499
psoriasis	CTLA4	0.12903225806451613	35977003
psoriasis	CXCL10	0.010752688172043012	35977003
psoriasis	CXCL9	0.010752688172043012	35977003
colitis ulcerative/immunology	CD4	0.04277699859747545	34338882
colitis ulcerative/immunology	CD68	0.04277699859747545	34338882
thyroiditis/diagnostic imaging	sarcoidosis/diagnostic imaging	0.010752688172043012	33375984
colitis ulcerative/immunology	CD8A	0.0023375409069658717	34338882
colitis ulcerative/immunology	CD8A	0.0023375409069658717	34147519
thyroiditis/diagnostic imaging	hepatitis/diagnostic imaging	0.010752688172043012	33375984
colitis ulcerative/immunology	CTLA4	0.24263674614305747	34147519
psoriasis	PDCD1	0.2688172043010753	35977003
psoriasis	TCIM	0.010752688172043012	35977003
psoriasis	TNF	0.03225806451612904	35977003
thyroiditis/diagnostic imaging	pericarditis/diagnostic imaging	0.010752688172043012	33375984
vitamin d	immune checkpoint inhibitors/adverse effects	0.5698924731182795	36338892
thyroiditis/diagnostic imaging	encephalitis/diagnostic imaging	0.010752688172043012	33375984
drug synergism	sirolimus/therapeutic use	0.021505376344086023	34987517
colitis ulcerative/immunology	PDCD1	0.4675081813931744	34147519
drug synergism	myeloid-derived suppressor cells/metabolism	0.021505376344086023	33495297
escherichia coli infections/drug therapy	neoplasms/drug therapy	0.12903225806451613	34107499
drug synergism	drug-related side effects and adverse reactions/prevention & control	0.021505376344086023	34987517
escherichia coli infections/drug therapy	diarrhea/chemically induced	0.15053763440860218	34107499
receptors cxcr6/genetics	gene expression regulation/genetics	0.010752688172043012	32603654
thyroiditis/diagnostic imaging	colitis/diagnostic imaging	0.010752688172043012	33375984
escherichia coli infections/drug therapy	clostridium infections/chemically induced	0.010752688172043012	34107499
receptors cxcr6/genetics	receptors cxcr3/genetics	0.010752688172043012	32603654
escherichia coli infections/drug therapy	colitis/chemically induced	0.7419354838709677	34107499
receptors cxcr6/genetics	cd8-positive t-lymphocytes/cytology	0.010752688172043012	32603654
receptors cxcr6/genetics	inflammation/drug therapy	0.021505376344086023	32603654
receptors cxcr6/genetics	immune checkpoint inhibitors/adverse effects	0.5698924731182795	32603654
urothelium/drug effects	immune checkpoint inhibitors/administration & dosage	0.04301075268817205	32418993
pneumonia	colitis	0.04301075268817205	35432346
receptors cxcr6/genetics	myeloid cells/cytology	0.010752688172043012	32603654
urothelium/drug effects	colitis/chemically induced	0.7419354838709677	32418993
receptors cxcr6/genetics	ctla-4 antigen/immunology	0.010752688172043012	32603654
urothelium/drug effects	carcinoma non-small-cell lung/complications	0.010752688172043012	32418993
vitamin d	colitis/chemically induced	0.7419354838709677	36338892
drug synergism	azoxymethane/adverse effects	0.021505376344086023	33495297
thyroiditis/diagnostic imaging	pneumonia/diagnostic imaging	0.010752688172043012	33375984
urothelium/drug effects	drug-related side effects and adverse reactions	0.021505376344086023	32418993
urothelium/drug effects	melanoma/complications	0.03225806451612904	32418993
receptors cxcr6/genetics	colitis/drug therapy	0.03225806451612904	32603654
vitamin d	melanoma/drug therapy	0.05376344086021506	36338892
urothelium/drug effects	infliximab/administration & dosage	0.010752688172043012	32418993
drug synergism	immune checkpoint inhibitors/administration & dosage	0.08461898083216456	33495297
drug synergism	growth inhibitors/therapeutic use	0.021505376344086023	34987517
pneumonia	ligands	0.010752688172043012	35432346
drug synergism	colitis/chemically induced	0.935483870967742	33495297
drug synergism	phthalazines/administration & dosage	0.021505376344086023	33495297
receptors cxcr6/genetics	receptors antigen t-cell/genetics	0.010752688172043012	32603654
drug synergism	dextran sulfate/adverse effects	0.021505376344086023	33495297
urothelium/drug effects	ACAD8	0.021505376344086023	32418993
receptors cxcr6/genetics	t-lymphocytes regulatory/cytology	0.010752688172043012	32603654
pneumonia	CD274	0.16129032258064516	35432346
neoplasms	immune checkpoint inhibitors/adverse effects	0.7893541708408469	36389768
neoplasms	immune checkpoint inhibitors/adverse effects	0.7893541708408469	36189293
urothelium/drug effects	CRP	0.010752688172043012	32418993
drug synergism	colonic neoplasms/drug therapy	0.021505376344086023	33495297
pneumonia	CTLA4	0.12903225806451613	35432346
vitamin d	antineoplastic agents immunological/adverse effects	0.07526881720430108	36338892
drug synergism	phosphatidylinositol 3-kinases/metabolism	0.021505376344086023	34987517
drug synergism	antineoplastic agents immunological/therapeutic use	0.0638148667601683	34987517
colon/diagnostic imaging	immunosuppressive agents/pharmacology	0.010752688172043012	32414860
pneumonia	PDCD1	0.2688172043010753	35432346
drug synergism	lymphocytes tumor-infiltrating/immunology	0.021505376344086023	34987517
colon/diagnostic imaging	mucositis/chemically induced	0.010752688172043012	32414860
drug synergism	colitis/etiology	0.04277699859747545	34987517
receptors cxcr6/genetics	chemokines/metabolism	0.010752688172043012	32603654
drug synergism	immune checkpoint inhibitors/therapeutic use	0.04277699859747545	34987517
drug synergism	programmed cell death 1 receptor/antagonists & inhibitors	0.16549789621318373	34987517
receptors cxcr6/genetics	multigene family	0.010752688172043012	32603654
ustekinumab/therapeutic use	colitis ulcerative/drug therapy	0.021505376344086023	33567198
drug synergism	cell line tumor	0.00023375409069658717	33495297
drug synergism	cell line tumor	0.00023375409069658717	34987517
ustekinumab/therapeutic use	immune checkpoint inhibitors/adverse effects	0.5698924731182795	33567198
immune system diseases/drug therapy	immune checkpoint inhibitors/adverse effects	0.5698924731182795	36159840
drug synergism	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.021505376344086023	33495297
drug synergism	cd8-positive t-lymphocytes/immunology	0.021505376344086023	34987517
receptors cxcr3/genetics	cd8-positive t-lymphocytes/cytology	0.010752688172043012	32603654
receptors cxcr3/genetics	inflammation/drug therapy	0.021505376344086023	32603654
drug synergism	piperazines/administration & dosage	0.021505376344086023	33495297
drug synergism	cytotoxicity immunologic	0.021505376344086023	34987517
receptors cxcr3/genetics	immune checkpoint inhibitors/adverse effects	0.5698924731182795	32603654
drug synergism	APC	0.04277699859747545	33495297
receptors cxcr6/genetics	CTLA4	0.12903225806451613	32603654
drug synergism	ARG1	0.021505376344086023	33495297
receptors cxcr3/genetics	myeloid cells/cytology	0.010752688172043012	32603654
receptors cxcr3/genetics	ctla-4 antigen/immunology	0.010752688172043012	32603654
drug synergism	CD8A	0.10518934081346423	34987517
drug resistance/immunology	immune checkpoint inhibitors/adverse effects	0.5698924731182795	32414860
receptors cxcr6/genetics	PDCD1	0.2688172043010753	32603654
ustekinumab/therapeutic use	interleukin-23/antagonists & inhibitors	0.010752688172043012	33567198
drug synergism	MTOR	0.021505376344086023	34987517
drug synergism	PARP1	0.021505376344086023	33495297
drug synergism	PDCD1	0.07012622720897614	33495297
drug synergism	PDCD1	0.07012622720897614	34987517
drug synergism	TIPARP	0.021505376344086023	33495297
immune system diseases/drug therapy	colitis/chemically induced	0.7419354838709677	36159840
adrenal cortex hormones/therapeutic use	inflammation/drug therapy	0.0638148667601683	36113896
drug resistance/immunology	skin neoplasms/drug therapy	0.021505376344086023	32414860
drug resistance/immunology	infliximab/adverse effects	0.04301075268817205	32414860
adrenal cortex hormones/therapeutic use	immune checkpoint inhibitors/adverse effects	0.9238629533159688	34380976
receptors cxcr3/genetics	colitis/drug therapy	0.03225806451612904	32603654
immune system diseases/drug therapy	antineoplastic agents immunological/therapeutic use	0.03225806451612904	36159840
adrenal cortex hormones/therapeutic use	immune checkpoint inhibitors	0.24247491638795987	36113896
adrenal cortex hormones/therapeutic use	immune checkpoint inhibitors	0.24247491638795987	32641348
adrenal cortex hormones/therapeutic use	skin neoplasms/drug therapy	0.0638148667601683	32641348
immune system diseases/drug therapy	gastrointestinal neoplasms/drug therapy	0.010752688172043012	36159840
adrenal cortex hormones/therapeutic use	tumor necrosis factor inhibitors	0.03225806451612903	32641348
receptors cxcr3/genetics	receptors antigen t-cell/genetics	0.010752688172043012	32603654
drug resistance/immunology	colitis/chemically induced	0.7419354838709677	32414860
protective agents/pharmacology	mesalamine/pharmacology	0.010752688172043012	33506015
receptors cxcr3/genetics	t-lymphocytes regulatory/cytology	0.010752688172043012	32603654
protective agents/pharmacology	colon/drug effects	0.03225806451612904	33506015
drug resistance/immunology	glucocorticoids/pharmacology	0.010752688172043012	32414860
ustekinumab/therapeutic use	interleukin-12/antagonists & inhibitors	0.010752688172043012	33567198
adrenal cortex hormones/therapeutic use	neoplasms/drug therapy	0.3425088235747422	34380976
adrenal cortex hormones/therapeutic use	diarrhea/chemically induced	0.0028050490883590466	36113896
adrenal cortex hormones/therapeutic use	diarrhea/chemically induced	0.0028050490883590466	32641348
adrenal cortex hormones/therapeutic use	diarrhea/chemically induced	0.0028050490883590466	34380976
immune system diseases/drug therapy	BTLA	0.010752688172043012	36159840
adrenal cortex hormones/therapeutic use	colitis/chemically induced	0.4037575327897907	36113896
adrenal cortex hormones/therapeutic use	colitis/chemically induced	0.4037575327897907	32641348
adrenal cortex hormones/therapeutic use	colitis/chemically induced	0.4037575327897907	34380976
immune system diseases/drug therapy	CD274	0.16129032258064516	36159840
immune system diseases/drug therapy	CD28	0.010752688172043012	36159840
drug resistance/immunology	melanoma/drug therapy	0.05376344086021506	32414860
immune system diseases/drug therapy	CSF2	0.010752688172043012	36159840
receptors cxcr3/genetics	chemokines/metabolism	0.010752688172043012	32603654
immune system diseases/drug therapy	HAVCR2	0.010752688172043012	36159840
immune system diseases/drug therapy	IL15	0.010752688172043012	36159840
receptors cxcr3/genetics	multigene family	0.010752688172043012	32603654
immune system diseases/drug therapy	IL17C	0.010752688172043012	36159840
protective agents/pharmacology	colitis/chemically induced	0.7419354838709677	33506015
immune system diseases/drug therapy	IL21	0.010752688172043012	36159840
immune system diseases/drug therapy	IL22	0.021505376344086023	36159840
immune system diseases/drug therapy	IL4	0.010752688172043012	36159840
drug resistance/immunology	immunosuppressive agents/pharmacology	0.010752688172043012	32414860
pyrimidines/therapeutic use	protein kinase inhibitors/therapeutic use	0.021505376344086023	33096100
adrenal cortex hormones/therapeutic use	melanoma/drug therapy	0.15435476164788925	32641348
virus diseases/etiology	immune checkpoint inhibitors/adverse effects	0.5698924731182795	34107499
protective agents/pharmacology	immune checkpoint inhibitors/pharmacology	0.04301075268817205	33506015
pyrimidines/therapeutic use	neoplasms/drug therapy	0.24263674614305747	33096100
drug resistance/immunology	mucositis/chemically induced	0.010752688172043012	32414860
receptors cxcr3/genetics	CTLA4	0.12903225806451613	32603654
pyrimidines/therapeutic use	ipilimumab/adverse effects	0.18513323983169702	33096100
protective agents/pharmacology	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	33506015
pyrimidines/therapeutic use	colitis/chemically induced	0.935483870967742	33096100
protective agents/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0.010752688172043012	33506015
receptors cxcr3/genetics	PDCD1	0.2688172043010753	32603654
adrenal cortex hormones/therapeutic use	biological products/therapeutic use	0.03225806451612903	34380976
virus diseases/etiology	neoplasms/drug therapy	0.12903225806451613	34107499
adrenal cortex hormones/therapeutic use	beclomethasone/adverse effects	0.03225806451612903	36113896
virus diseases/etiology	diarrhea/chemically induced	0.15053763440860218	34107499
pneumonia	immune checkpoint inhibitors/adverse effects	0.5698924731182795	35432346
virus diseases/etiology	clostridium infections/chemically induced	0.010752688172043012	34107499
pyrimidines/therapeutic use	piperidines/therapeutic use	0.00023375409069658717	33096100
pyrimidines/therapeutic use	piperidines/therapeutic use	0.00023375409069658717	34147519
protective agents/pharmacology	ACAD8	0.021505376344086023	33506015
virus diseases/etiology	colitis/chemically induced	0.7419354838709677	34107499
pyrimidines/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.16549789621318373	34147519
virus diseases/etiology	anti-bacterial agents/adverse effects	0.010752688172043012	34107499
pyrimidines/therapeutic use	ctla-4 antigen/antagonists & inhibitors	0.0638148667601683	34147519
colitis ulcerative/drug therapy	immune checkpoint inhibitors/adverse effects	0.8176718092566619	33567198
pyrimidines/therapeutic use	cd8-positive t-lymphocytes/drug effects	0.04277699859747545	34147519
arthritis/chemically induced	immune checkpoint inhibitors	0.3225806451612903	36096534
pyrimidines/therapeutic use	phenotype	0.04277699859747545	34147519
arthritis/chemically induced	glucocorticoids	0.010752688172043012	36096534
colitis ulcerative/drug therapy	immune checkpoint inhibitors	0.5434782608695652	33058056
pyrimidines/therapeutic use	CD8A	0.10518934081346423	34147519
colitis collagenous/drug therapy	immune checkpoint inhibitors/pharmacology	0.04301075268817205	32404733
pyrimidines/therapeutic use	CTLA4	0.24263674614305747	34147519
glycoproteins/metabolism	b7-h1 antigen/antagonists & inhibitors	0.03225806451612904	32389505
pyrimidines/therapeutic use	PDCD1	0.4675081813931744	34147519
colitis collagenous/drug therapy	melanoma/complications	0.03225806451612904	32404733
glycoproteins/metabolism	colitis/chemically induced	0.7419354838709677	32389505
arthritis/chemically induced	diarrhea/chemically induced	0.15053763440860218	36096534
myocarditis/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5698924731182795	33375984
glycoproteins/metabolism	biomarkers/metabolism	0.010752688172043012	32389505
myocarditis/diagnostic imaging	pancreatitis/diagnostic imaging	0.010752688172043012	33375984
arthritis/chemically induced	colitis/chemically induced	0.7419354838709677	36096534
myocarditis/diagnostic imaging	neoplasms/diagnostic imaging	0.021505376344086023	33375984
colitis ulcerative/drug therapy	interleukin-23/antagonists & inhibitors	0.021505376344086023	33567198
glycoproteins/metabolism	adenocarcinoma of lung/drug therapy	0.010752688172043012	32389505
myocarditis/diagnostic imaging	sarcoidosis/diagnostic imaging	0.010752688172043012	33375984
diabetes mellitus type 1/chemically induced	exanthema/chemically induced	0.010752688172043012	32130969
diabetes mellitus type 1/chemically induced	bevacizumab/administration & dosage	0.010752688172043012	32130969
myocarditis/diagnostic imaging	hepatitis/diagnostic imaging	0.010752688172043012	33375984
diabetes mellitus type 1/chemically induced	pneumonia/chemically induced	0.03225806451612904	32130969
colitis ulcerative/drug therapy	crohn disease/drug therapy	0.021505376344086023	33058056
diabetes mellitus type 1/chemically induced	fatigue/chemically induced	0.010752688172043012	32130969
colitis collagenous/drug therapy	PDCD1	0.2688172043010753	32404733
glycoproteins/metabolism	CD274	0.16129032258064516	32389505
myocarditis/diagnostic imaging	pericarditis/diagnostic imaging	0.010752688172043012	33375984
neoplasm recurrence local/drug therapy	immune checkpoint inhibitors	0.3225806451612903	35801666
myocarditis/diagnostic imaging	encephalitis/diagnostic imaging	0.010752688172043012	33375984
diabetes mellitus type 1/chemically induced	pruritus/chemically induced	0.010752688172043012	32130969
diabetes mellitus type 1/chemically induced	adrenal insufficiency/chemically induced	0.010752688172043012	32130969
pancreatitis/diagnostic imaging	neoplasms/diagnostic imaging	0.021505376344086023	33375984
myocarditis/diagnostic imaging	colitis/diagnostic imaging	0.010752688172043012	33375984
diabetes mellitus type 1/chemically induced	axitinib/administration & dosage	0.010752688172043012	32130969
colitis ulcerative/drug therapy	interleukin-12/antagonists & inhibitors	0.021505376344086023	33567198
arthritis/chemically induced	CHI3L1	0.010752688172043012	36096534
arthritis/chemically induced	CXCL8	0.010752688172043012	36096534
pancreatitis/diagnostic imaging	sarcoidosis/diagnostic imaging	0.010752688172043012	33375984
arthritis/chemically induced	IL17A	0.021505376344086023	36096534
diabetes mellitus type 1/chemically induced	colitis/chemically induced	0.7419354838709677	32130969
pancreatitis/diagnostic imaging	hepatitis/diagnostic imaging	0.010752688172043012	33375984
neoplasm recurrence local/drug therapy	colitis/chemically induced	0.7419354838709677	35801666
arthritis/chemically induced	IL6	0.021505376344086023	36096534
diabetes mellitus type 1/chemically induced	hypophysitis/chemically induced	0.010752688172043012	32130969
cd8-positive t-lymphocytes/cytology	inflammation/drug therapy	0.021505376344086023	32603654
cd8-positive t-lymphocytes/cytology	immune checkpoint inhibitors/adverse effects	0.5698924731182795	32603654
neoplasm recurrence local/drug therapy	endometrial neoplasms/drug therapy	0.010752688172043012	35801666
diabetes mellitus type 1/chemically induced	angiogenesis inhibitors/therapeutic use	0.010752688172043012	32130969
cd8-positive t-lymphocytes/cytology	myeloid cells/cytology	0.010752688172043012	32603654
myeloid cells/cytology	ctla-4 antigen/immunology	0.010752688172043012	32603654
pancreatitis/diagnostic imaging	pericarditis/diagnostic imaging	0.010752688172043012	33375984
cd8-positive t-lymphocytes/cytology	ctla-4 antigen/immunology	0.010752688172043012	32603654
pancreatitis/diagnostic imaging	encephalitis/diagnostic imaging	0.010752688172043012	33375984
diabetes mellitus type 1/chemically induced	myocarditis/chemically induced	0.010752688172043012	32130969
neoplasm recurrence local/drug therapy	antibodies monoclonal humanized	0.010752688172043012	35801666
myocarditis/diagnostic imaging	pneumonia/diagnostic imaging	0.010752688172043012	33375984
diabetes mellitus type 1/chemically induced	hepatitis autoimmune/etiology	0.010752688172043012	32130969
pancreatitis/diagnostic imaging	colitis/diagnostic imaging	0.010752688172043012	33375984
diabetes mellitus type 1/chemically induced	myasthenia gravis/chemically induced	0.010752688172043012	32130969
diabetes mellitus type 1/chemically induced	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
cd8-positive t-lymphocytes/cytology	colitis/drug therapy	0.03225806451612904	32603654
myeloid cells/cytology	colitis/drug therapy	0.03225806451612904	32603654
diabetes mellitus type 1/chemically induced	ipilimumab/therapeutic use	0.03225806451612904	32130969
cd8-positive t-lymphocytes/cytology	receptors antigen t-cell/genetics	0.010752688172043012	32603654
pancreatitis/diagnostic imaging	pneumonia/diagnostic imaging	0.010752688172043012	33375984
myeloid cells/cytology	receptors antigen t-cell/genetics	0.010752688172043012	32603654
skin neoplasms/complications	colitis collagenous/drug therapy	0.010752688172043012	32404733
cd8-positive t-lymphocytes/cytology	t-lymphocytes regulatory/cytology	0.010752688172043012	32603654
myeloid cells/cytology	t-lymphocytes regulatory/cytology	0.010752688172043012	32603654
neoplasm recurrence local/drug therapy	PDCD1	0.2688172043010753	35801666
cd8-positive t-lymphocytes/cytology	chemokines/metabolism	0.010752688172043012	32603654
immune checkpoint inhibitors	glucocorticoids	0.32258064516129037	36096534
cd8-positive t-lymphocytes/cytology	multigene family	0.010752688172043012	32603654
immune checkpoint inhibitors	skin neoplasms/drug therapy	0.5434782608695652	32641348
myeloid cells/cytology	chemokines/metabolism	0.010752688172043012	32603654
immune checkpoint inhibitors	infliximab/adverse effects	0.38795986622073575	32162824
immune checkpoint inhibitors	infliximab/adverse effects	0.38795986622073575	32584703
immune checkpoint inhibitors	lung neoplasms/drug therapy	0.5434782608695652	34716545
myeloid cells/cytology	multigene family	0.010752688172043012	32603654
immune checkpoint inhibitors	diarrhea/therapy	0.32258064516129037	32780984
neoplasms/diagnostic imaging	sarcoidosis/diagnostic imaging	0.021505376344086023	33375984
immune checkpoint inhibitors	tumor necrosis factor inhibitors	0.32258064516129037	32641348
immune checkpoint inhibitors	colitis	0.09698996655518395	33314269
immune checkpoint inhibitors	colitis	0.09698996655518395	35842365
immune checkpoint inhibitors	colitis	0.09698996655518395	32780983
neoplasms/diagnostic imaging	hepatitis/diagnostic imaging	0.021505376344086023	33375984
micrornas/genetics	gene expression regulation neoplastic	0.010752688172043012	33462141
micrornas/genetics	lymphocytes tumor-infiltrating/metabolism	0.010752688172043012	33462141
neoplasms/diagnostic imaging	pericarditis/diagnostic imaging	0.021505376344086023	33375984
immune checkpoint inhibitors	carcinoma non-small-cell lung/drug therapy	0.5434782608695652	35124713
neoplasms/diagnostic imaging	encephalitis/diagnostic imaging	0.021505376344086023	33375984
immune checkpoint inhibitors	inflammatory bowel diseases/drug therapy	0.6939799331103679	33314269
neoplasms/diagnostic imaging	colitis/chemically induced	0.935483870967742	31754740
cd8-positive t-lymphocytes/cytology	CTLA4	0.12903225806451613	32603654
skin neoplasms/complications	immune checkpoint inhibitors/pharmacology	0.04301075268817205	32404733
immune checkpoint inhibitors	colitis microscopic/chemically induced	0.10168302945301541	34170536
immune checkpoint inhibitors	colitis microscopic/chemically induced	0.10168302945301541	32401685
immune checkpoint inhibitors	colitis/drug therapy	0.6939799331103679	32780984
micrornas/genetics	t-lymphocytes cytotoxic/immunology	0.010752688172043012	33462141
immune checkpoint inhibitors	recurrence	0.32258064516129037	35842365
myeloid cells/cytology	CTLA4	0.12903225806451613	32603654
micrornas/genetics	tumor microenvironment/drug effects	0.010752688172043012	33462141
immune checkpoint inhibitors	diarrhea/chemically induced	0.4933396361351056	32641348
immune checkpoint inhibitors	diarrhea/chemically induced	0.4933396361351056	36113896
immune checkpoint inhibitors	diarrhea/chemically induced	0.4933396361351056	35917654
immune checkpoint inhibitors	diarrhea/chemically induced	0.4933396361351056	36096534
immune checkpoint inhibitors	diarrhea/chemically induced	0.4933396361351056	32584703
neoplasms/diagnostic imaging	colitis/diagnostic imaging	0.021505376344086023	33375984
immune checkpoint inhibitors	immunologic factors	0.10168302945301541	33566405
immune checkpoint inhibitors	immunologic factors	0.10168302945301541	33566423
cd8-positive t-lymphocytes/cytology	PDCD1	0.2688172043010753	32603654
immune checkpoint inhibitors	ipilimumab/adverse effects	0.6043739907978188	35191192
immune checkpoint inhibitors	ipilimumab/adverse effects	0.6043739907978188	32934876
immune checkpoint inhibitors	ipilimumab/adverse effects	0.6043739907978188	35917654
skin neoplasms/complications	melanoma/complications	0.03225806451612904	32404733
immune checkpoint inhibitors	neoplasms/therapy	0.32258064516129037	32780984
myeloid cells/cytology	PDCD1	0.2688172043010753	32603654
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	34081152
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	34716545
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	32162824
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	36096534
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	35307927
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	35191192
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	34106395
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	34515105
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	35977003
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	35296560
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	34256056
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	35801666
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	32641348
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	33566405
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	35917654
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	32934876
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	36113896
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	35124713
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	31864555
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	33746162
immune checkpoint inhibitors	colitis/chemically induced	0.8143583149525486	32584703
micrornas/genetics	immune checkpoint inhibitors/administration & dosage	0.04301075268817205	33462141
micrornas/genetics	ht29 cells	0.010752688172043012	33462141
neoplasms/diagnosis	pneumonia/chemically induced	0.03225806451612904	32540858
micrornas/genetics	colitis/chemically induced	0.7419354838709677	33462141
immune checkpoint inhibitors	endometrial neoplasms/drug therapy	0.32258064516129037	35801666
immune checkpoint inhibitors	dermatitis	0.32258064516129037	35977003
micrornas/genetics	colorectal neoplasms/drug therapy	0.010752688172043012	33462141
neoplasms/diagnosis	antibodies monoclonal humanized/administration & dosage	0.010752688172043012	32540858
immune checkpoint inhibitors	antibodies monoclonal humanized	0.32258064516129037	35801666
micrornas/genetics	b7-h1 antigen/genetics	0.010752688172043012	33462141
immune checkpoint inhibitors	melanoma/drug therapy	0.5209124046446958	32162824
immune checkpoint inhibitors	melanoma/drug therapy	0.5209124046446958	32641348
immune checkpoint inhibitors	crohn disease/drug therapy	0.32258064516129037	33058056
skin neoplasms/complications	PDCD1	0.2688172043010753	32404733
tryptophan/pharmacology	neoplasms/drug therapy	0.12903225806451613	35236743
immune checkpoint inhibitors	drug-related side effects and adverse reactions/diagnosis	0.32258064516129037	35191192
immune checkpoint inhibitors	inflammatory bowel diseases	0.5434782608695652	35842365
immune checkpoint inhibitors/adverse effects	myeloid cells/cytology	0.5698924731182795	32603654
neoplasms/diagnostic imaging	pneumonia/diagnostic imaging	0.021505376344086023	33375984
immune checkpoint inhibitors/adverse effects	colitis ulcerative/physiopathology	0.5698924731182795	34821404
immune checkpoint inhibitors/adverse effects	myasthenia gravis/diagnosis	0.5698924731182795	34956219
immune checkpoint inhibitors	drug-related side effects and adverse reactions	0.5434782608695652	32162824
immune checkpoint inhibitors/adverse effects	ctla-4 antigen/immunology	0.5698924731182795	32603654
immune checkpoint inhibitors/adverse effects	glycoproteins/metabolism	0.5698924731182795	32389505
tryptophan/pharmacology	colitis/chemically induced	0.7419354838709677	35236743
immune checkpoint inhibitors/adverse effects	pancreatitis/diagnostic imaging	0.5698924731182795	33375984
immune checkpoint inhibitors/adverse effects	neoplasms/diagnostic imaging	0.3221131369798972	33375984
immune checkpoint inhibitors/adverse effects	neoplasms/diagnostic imaging	0.3221131369798972	31754740
neoplasms/diagnosis	immune checkpoint inhibitors/administration & dosage	0.04301075268817205	32540858
immune checkpoint inhibitors/adverse effects	colitis/diagnosis	0.817671809256662	32028372
immune checkpoint inhibitors	lung neoplasms	0.32258064516129037	31864555
immune checkpoint inhibitors/adverse effects	immunosuppressive agents/therapeutic use	0.5698924731182795	34956219
immune checkpoint inhibitors	cd8-positive t-lymphocytes	0.32258064516129037	34106395
immune checkpoint inhibitors/adverse effects	macrophages/drug effects	0.5698924731182795	34338882
immune checkpoint inhibitors	beclomethasone/adverse effects	0.32258064516129037	36113896
neoplasms/diagnosis	colitis/chemically induced	0.7419354838709677	32540858
immune checkpoint inhibitors	ipilimumab/therapeutic use	0.6939799331103679	35124713
immune checkpoint inhibitors/adverse effects	mycophenolic acid	0.5698924731182795	36504035
immune checkpoint inhibitors	cytomegalovirus infections/complications	0.32258064516129037	35307927
immune checkpoint inhibitors/adverse effects	interferon-gamma/metabolism	0.5698924731182795	34147519
immune checkpoint inhibitors	inflammatory bowel diseases/complications	0.5434782608695652	32401685
immune checkpoint inhibitors/adverse effects	immunologic memory/drug effects	0.5698924731182795	34147519
tryptophan/pharmacology	immune checkpoint inhibitors/pharmacology	0.04301075268817205	35236743
immune checkpoint inhibitors	rna	0.32258064516129037	35977003
immune checkpoint inhibitors	steroids/therapeutic use	0.5434782608695652	31864555
immune checkpoint inhibitors/adverse effects	skin neoplasms/drug therapy	0.817671809256662	32414860
immune checkpoint inhibitors/adverse effects	colon/drug effects	0.6052895211380485	34338882
immune checkpoint inhibitors/adverse effects	colon/drug effects	0.6052895211380485	34147519
immune checkpoint inhibitors/adverse effects	infliximab/adverse effects	0.7893541708408469	32414860
immune checkpoint inhibitors/adverse effects	infliximab/adverse effects	0.7893541708408469	33454238
immune checkpoint inhibitors/adverse effects	lung neoplasms/drug therapy	0.817671809256662	33173388
immune checkpoint inhibitors	CD274	0.9257828194908216	32934876
immune checkpoint inhibitors	CD274	0.9257828194908216	33314269
immune checkpoint inhibitors	CD274	0.9257828194908216	35917654
immune checkpoint inhibitors/adverse effects	disease progression	0.5698924731182795	36377339
immune checkpoint inhibitors	CHI3L1	0.32258064516129037	36096534
immune checkpoint inhibitors/adverse effects	colitis	0.9686992141410093	35432346
immune checkpoint inhibitors	CTLA4	0.33034437571557845	35977003
immune checkpoint inhibitors	CTLA4	0.33034437571557845	35917654
immune checkpoint inhibitors	CTLA4	0.33034437571557845	35191192
immune checkpoint inhibitors	CTLA4	0.33034437571557845	32934876
immune checkpoint inhibitors	CTLA4	0.33034437571557845	33314269
immune checkpoint inhibitors/adverse effects	gastritis/chemically induced	0.5698924731182795	32621258
immune checkpoint inhibitors	CXCL10	0.32258064516129037	35977003
immune checkpoint inhibitors	CXCL8	0.32258064516129037	36096534
immune checkpoint inhibitors/adverse effects	protein kinase inhibitors/therapeutic use	0.5698924731182795	33096100
immune checkpoint inhibitors	CXCL9	0.32258064516129037	35977003
immune checkpoint inhibitors/adverse effects	colitis/epidemiology	0.5698924731182795	32960847
immune checkpoint inhibitors	IL17A	0.5434782608695652	36096534
immune checkpoint inhibitors/adverse effects	sarcoidosis/diagnostic imaging	0.5698924731182795	33375984
immune checkpoint inhibitors/adverse effects	squamous cell carcinoma of head and neck/drug therapy	0.5698924731182795	33476895
immune checkpoint inhibitors	IL6	0.5434782608695652	36096534
immune checkpoint inhibitors/adverse effects	tongue neoplasms/drug therapy	0.5698924731182795	33476895
micrornas/genetics	APC	0.021505376344086023	33462141
immune checkpoint inhibitors	LTF	0.32258064516129037	32584703
immune checkpoint inhibitors/adverse effects	carcinoma non-small-cell lung/drug therapy	0.817671809256662	34992611
micrornas/genetics	CD274	0.16129032258064516	33462141
immune checkpoint inhibitors	PDCD1	0.9022632386477186	35801666
immune checkpoint inhibitors	PDCD1	0.9022632386477186	35977003
immune checkpoint inhibitors	PDCD1	0.9022632386477186	32401685
immune checkpoint inhibitors	PDCD1	0.9022632386477186	35917654
immune checkpoint inhibitors	PDCD1	0.9022632386477186	35191192
immune checkpoint inhibitors	PDCD1	0.9022632386477186	33314269
immune checkpoint inhibitors/adverse effects	gentian violet	0.5698924731182795	32888202
immune checkpoint inhibitors	SNCA	0.24247491638795982	32934876
immune checkpoint inhibitors	SNCA	0.24247491638795982	32641348
immune checkpoint inhibitors	TCIM	0.32258064516129037	35977003
immune checkpoint inhibitors/adverse effects	hepatitis/diagnostic imaging	0.5698924731182795	33375984
micrornas/genetics	CD8A	0.05376344086021506	33462141
immune checkpoint inhibitors	TNF	0.03128708598554321	32162824
immune checkpoint inhibitors	TNF	0.03128708598554321	35977003
immune checkpoint inhibitors	TNF	0.03128708598554321	32641348
immune checkpoint inhibitors/adverse effects	chemical and drug induced liver injury/diagnosis	0.5698924731182795	33080231
neoplasms/diagnosis	dose-response relationship drug	0.021505376344086023	32540858
immune checkpoint inhibitors/adverse effects	b7-h1 antigen/antagonists & inhibitors	0.1805249449008215	32389505
immune checkpoint inhibitors/adverse effects	b7-h1 antigen/antagonists & inhibitors	0.1805249449008215	32702598
immune checkpoint inhibitors/adverse effects	b7-h1 antigen/antagonists & inhibitors	0.1805249449008215	32960847
fatigue/chemically induced	pruritus/chemically induced	0.010752688172043012	32130969
tryptophan/pharmacology	AHR	0.010752688172043012	35236743
immune checkpoint inhibitors/adverse effects	inflammatory bowel diseases/drug therapy	0.6052895211380485	33555016
immune checkpoint inhibitors/adverse effects	inflammatory bowel diseases/drug therapy	0.6052895211380485	35277350
immune checkpoint inhibitors/adverse effects	antibodies monoclonal humanized/therapeutic use	0.5698924731182795	33454238
immune checkpoint inhibitors/adverse effects	skin neoplasms/immunology	0.5698924731182795	34956219
micrornas/genetics	IL17A	0.021505376344086023	33462141
immune checkpoint inhibitors/adverse effects	steroids/adverse effects	0.5698924731182795	33454238
neoplasms/diagnosis	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	32540858
immune checkpoint inhibitors/adverse effects	lymphocytes/drug effects	0.5698924731182795	32567084
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.007959418362813784	33741313
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.007959418362813784	33096100
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.007959418362813784	31609734
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.007959418362813784	33080231
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.007959418362813784	33436487
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.007959418362813784	33459466
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.007959418362813784	34777387
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.007959418362813784	34107499
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.007959418362813784	34380976
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.007959418362813784	32185493
immune checkpoint inhibitors/adverse effects	neoplasms/drug therapy	0.007959418362813784	36377339
immune checkpoint inhibitors/adverse effects	feces	0.5698924731182795	33290513
micrornas/genetics	MIR15B	0.010752688172043012	33462141
immune checkpoint inhibitors/adverse effects	colitis/drug therapy	0.6052895211380485	32603654
immune checkpoint inhibitors/adverse effects	colitis/drug therapy	0.6052895211380485	33436487
fatigue/chemically induced	adrenal insufficiency/chemically induced	0.010752688172043012	32130969
immune checkpoint inhibitors/adverse effects	crohn disease/physiopathology	0.5698924731182795	34821404
micrornas/genetics	NRF1	0.010752688172043012	33462141
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.3839854950323438	31609734
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.3839854950323438	33436487
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.3839854950323438	34107499
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.3839854950323438	33173388
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.3839854950323438	34158318
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.3839854950323438	34380976
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.3839854950323438	33290513
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.3839854950323438	31595568
immune checkpoint inhibitors/adverse effects	diarrhea/chemically induced	0.3839854950323438	36377339
tryptophan/pharmacology	IL22	0.021505376344086023	35236743
micrornas/genetics	PDCD1	0.2688172043010753	33462141
immune checkpoint inhibitors/adverse effects	proton pump inhibitors/adverse effects	0.5698924731182795	35277350
immune checkpoint inhibitors/adverse effects	pericarditis/diagnostic imaging	0.5698924731182795	33375984
fatigue/chemically induced	axitinib/administration & dosage	0.010752688172043012	32130969
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.4022890528441667	34159488
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.4022890528441667	33096100
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.4022890528441667	33882697
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.4022890528441667	34332139
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.4022890528441667	31595568
immune checkpoint inhibitors/adverse effects	ipilimumab/adverse effects	0.4022890528441667	32931028
immune checkpoint inhibitors/adverse effects	encephalitis/diagnostic imaging	0.5698924731182795	33375984
immune checkpoint inhibitors/adverse effects	dysbiosis/etiology	0.5698924731182795	34162429
immune checkpoint inhibitors/adverse effects	clostridium infections/chemically induced	0.5698924731182795	34107499
inflammation/drug therapy	immune checkpoint inhibitors/adverse effects	0.8176718092566619	32603654
immune checkpoint inhibitors/adverse effects	anti-bacterial agents	0.5698924731182795	36043345
metabolome/drug effects	immune checkpoint inhibitors/adverse effects	0.5698924731182795	34162429
inflammation/drug therapy	myeloid cells/cytology	0.021505376344086023	32603654
mycophenolic acid	colitis/chemically induced	0.7419354838709677	36504035
immune checkpoint inhibitors/adverse effects	interleukin-23/antagonists & inhibitors	0.5698924731182795	33567198
neoplasms/diagnosis	drugs investigational/administration & dosage	0.010752688172043012	32540858
inflammation/drug therapy	ctla-4 antigen/immunology	0.021505376344086023	32603654
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	34159488
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	33741313
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	32389505
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	34751747
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	32422528
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	32702598
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	31609734
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	36389768
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	33459466
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	33268234
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	33173388
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	32888202
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	32414860
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	33290513
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	32185493
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	33454238
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	33096100
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	35277350
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	33080231
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	34777387
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	32567084
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	34380976
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	31595568
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	34956219
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	32434876
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	33555016
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	33882697
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	33906378
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	32621258
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	36338892
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	36043345
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	32931028
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	36159840
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	36504035
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	34992611
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	34332139
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	34107499
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	36189293
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	34158318
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	31754740
immune checkpoint inhibitors/adverse effects	colitis/chemically induced	0.28552761772611	36377339
immune checkpoint inhibitors/adverse effects	neoplasms/complications	0.1805249449008215	34162429
immune checkpoint inhibitors/adverse effects	neoplasms/complications	0.1805249449008215	34158318
immune checkpoint inhibitors/adverse effects	neoplasms/complications	0.1805249449008215	32960847
immune checkpoint inhibitors/adverse effects	abdominal pain/chemically induced	0.5698924731182795	36377339
inflammation/drug therapy	immune checkpoint inhibitors	0.5434782608695652	36113896
immune checkpoint inhibitors/adverse effects	crohn disease/immunology	0.5698924731182795	34338882
immune checkpoint inhibitors/adverse effects	glucocorticoids/pharmacology	0.5698924731182795	32414860
immune checkpoint inhibitors/adverse effects	cytomegalovirus infections/diagnosis	0.5698924731182795	32434876
fatigue/chemically induced	colitis/chemically induced	0.7419354838709677	32130969
immune checkpoint inhibitors/adverse effects	paclitaxel/therapeutic use	0.5698924731182795	33476895
neoplasms/diagnosis	CD274	0.16129032258064516	32540858
immune checkpoint inhibitors/adverse effects	receptors antigen t-cell/genetics	0.5698924731182795	32603654
fatigue/chemically induced	hypophysitis/chemically induced	0.010752688172043012	32130969
immune checkpoint inhibitors/adverse effects	biomarkers/metabolism	0.5698924731182795	32389505
immune checkpoint inhibitors/adverse effects	colitis/diagnostic imaging	0.5698924731182795	33375984
immune checkpoint inhibitors/adverse effects	anti-bacterial agents/adverse effects	0.5698924731182795	34107499
immune checkpoint inhibitors/adverse effects	oropharyngeal neoplasms/drug therapy	0.5698924731182795	33906378
fatigue/chemically induced	angiogenesis inhibitors/therapeutic use	0.010752688172043012	32130969
immune checkpoint inhibitors/adverse effects	vitamin d/administration & dosage	0.5698924731182795	32567084
inflammation/drug therapy	colitis/drug therapy	0.0638148667601683	32603654
immune checkpoint inhibitors/adverse effects	melanoma/immunology	0.5698924731182795	34956219
inflammation/drug therapy	diarrhea/chemically induced	0.27980364656381496	36113896
immune checkpoint inhibitors/adverse effects	t-lymphocytes regulatory/cytology	0.5698924731182795	32603654
immune checkpoint inhibitors/adverse effects	intestinal mucosa/immunology	0.5698924731182795	33459466
fatigue/chemically induced	myocarditis/chemically induced	0.010752688172043012	32130969
immune checkpoint inhibitors/adverse effects	disease susceptibility	0.5698924731182795	32028372
immune checkpoint inhibitors/adverse effects	colitis ulcerative/chemically induced	0.5698924731182795	33476895
neoplasms/diagnosis	PDCD1	0.2688172043010753	32540858
immune checkpoint inhibitors/adverse effects	feces/chemistry	0.5698924731182795	33436487
inflammation/drug therapy	colitis/chemically induced	0.935483870967742	36113896
immune checkpoint inhibitors/adverse effects	melanoma/drug therapy	0.6321753688474461	33882697
immune checkpoint inhibitors/adverse effects	melanoma/drug therapy	0.6321753688474461	36338892
immune checkpoint inhibitors/adverse effects	melanoma/drug therapy	0.6321753688474461	32414860
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/therapeutic use	0.6052895211380485	36159840
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/therapeutic use	0.6052895211380485	36377339
fatigue/chemically induced	hepatitis autoimmune/etiology	0.010752688172043012	32130969
immune checkpoint inhibitors/adverse effects	piperidines/therapeutic use	0.3221131369798972	33096100
immune checkpoint inhibitors/adverse effects	piperidines/therapeutic use	0.3221131369798972	34147519
immune checkpoint inhibitors/adverse effects	adrenal cortex hormones/pharmacology	0.5698924731182795	33268234
inflammation/drug therapy	receptors antigen t-cell/genetics	0.021505376344086023	32603654
immune checkpoint inhibitors/adverse effects	immunocompromised host	0.5698924731182795	34956219
immune checkpoint inhibitors/adverse effects	colon/immunology	0.3221131369798972	33459466
immune checkpoint inhibitors/adverse effects	colon/immunology	0.3221131369798972	34777387
fatigue/chemically induced	myasthenia gravis/chemically induced	0.010752688172043012	32130969
immune checkpoint inhibitors/adverse effects	dose-response relationship drug	0.817671809256662	33290513
immune checkpoint inhibitors/adverse effects	neutrophils/drug effects	0.5698924731182795	32567084
metabolome/drug effects	dysbiosis/etiology	0.010752688172043012	34162429
immune checkpoint inhibitors/adverse effects	antibodies monoclonal/adverse effects	0.5698924731182795	32567084
fatigue/chemically induced	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
immune checkpoint inhibitors/adverse effects	colitis/etiology	0.817671809256662	34162429
inflammation/drug therapy	t-lymphocytes regulatory/cytology	0.021505376344086023	32603654
immune checkpoint inhibitors/adverse effects	immunosuppressive agents/pharmacology	0.5698924731182795	32414860
immune checkpoint inhibitors/adverse effects	leukocyte l1 antigen complex/analysis	0.5698924731182795	33436487
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.5234742109264886	34147519
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.5234742109264886	32702598
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.5234742109264886	32567084
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.5234742109264886	32960847
immune checkpoint inhibitors/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.5234742109264886	33476895
metabolome/drug effects	neoplasms/complications	0.03225806451612904	34162429
immune checkpoint inhibitors/adverse effects	gastrointestinal neoplasms/drug therapy	0.5698924731182795	36159840
immune checkpoint inhibitors/adverse effects	ligands	0.5698924731182795	35432346
immune checkpoint inhibitors/adverse effects	postoperative complications	0.5698924731182795	32028372
gene expression regulation neoplastic	lymphocytes tumor-infiltrating/metabolism	0.010752688172043012	33462141
immune checkpoint inhibitors/adverse effects	melanoma/complications	0.9238629533159688	32567084
immune checkpoint inhibitors/adverse effects	adenocarcinoma of lung/drug therapy	0.5698924731182795	32389505
immune checkpoint inhibitors/adverse effects	chemokines/metabolism	0.5698924731182795	32603654
immune checkpoint inhibitors/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.1805249449008215	32567084
immune checkpoint inhibitors/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.1805249449008215	32702598
immune checkpoint inhibitors/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.1805249449008215	34147519
immune checkpoint inhibitors/adverse effects	t-lymphocyte subsets/immunology	0.5698924731182795	34777387
inflammation/drug therapy	chemokines/metabolism	0.021505376344086023	32603654
immune checkpoint inhibitors/adverse effects	mucositis/chemically induced	0.5698924731182795	32414860
inflammation/drug therapy	multigene family	0.021505376344086023	32603654
immune checkpoint inhibitors/adverse effects	multigene family	0.5698924731182795	32603654
gene expression regulation neoplastic	t-lymphocytes cytotoxic/immunology	0.010752688172043012	33462141
fatigue/chemically induced	ipilimumab/therapeutic use	0.03225806451612904	32130969
immune checkpoint inhibitors/adverse effects	gastritis/complications	0.5698924731182795	36377339
gene expression regulation neoplastic	tumor microenvironment/drug effects	0.010752688172043012	33462141
immune checkpoint inhibitors/adverse effects	biological products/therapeutic use	0.5698924731182795	34380976
inflammation/drug therapy	beclomethasone/adverse effects	0.021505376344086023	36113896
immune checkpoint inhibitors/adverse effects	enterocolitis/chemically induced	0.3221131369798972	36377339
immune checkpoint inhibitors/adverse effects	enterocolitis/chemically induced	0.3221131369798972	34821404
colitis ulcerative/physiopathology	crohn disease/physiopathology	0.010752688172043012	34821404
immune checkpoint inhibitors/adverse effects	graft vs host disease/immunology	0.5698924731182795	34338882
immune checkpoint inhibitors/adverse effects	hepatitis/diagnosis	0.5698924731182795	32185493
gene expression regulation neoplastic	immune checkpoint inhibitors/administration & dosage	0.04301075268817205	33462141
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.016270764526575002	32422528
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.016270764526575002	32702598
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.016270764526575002	32567084
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.016270764526575002	36338892
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.016270764526575002	32434876
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.016270764526575002	34162429
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.016270764526575002	33476895
immune checkpoint inhibitors/adverse effects	ipilimumab/therapeutic use	0.9238629533159688	35277350
gene expression regulation neoplastic	ht29 cells	0.010752688172043012	33462141
immune checkpoint inhibitors/adverse effects	pneumonia/diagnostic imaging	0.5698924731182795	33375984
gene expression regulation neoplastic	colitis/chemically induced	0.7419354838709677	33462141
immune checkpoint inhibitors/adverse effects	interleukin-12/antagonists & inhibitors	0.5698924731182795	33567198
immune checkpoint inhibitors/adverse effects	cd8-positive t-lymphocytes/drug effects	0.3221131369798972	34338882
immune checkpoint inhibitors/adverse effects	cd8-positive t-lymphocytes/drug effects	0.3221131369798972	34147519
metabolome/drug effects	colitis/etiology	0.021505376344086023	34162429
immune checkpoint inhibitors/adverse effects	biomarkers/analysis	0.5698924731182795	33436487
inflammation/drug therapy	CTLA4	0.24263674614305747	32603654
immune checkpoint inhibitors/adverse effects	phenotype	0.3221131369798972	34338882
immune checkpoint inhibitors/adverse effects	phenotype	0.3221131369798972	34147519
immune checkpoint inhibitors/adverse effects	butyrates/metabolism	0.5698924731182795	33741313
gene expression regulation neoplastic	colorectal neoplasms/drug therapy	0.010752688172043012	33462141
immune checkpoint inhibitors/adverse effects	inflammatory bowel diseases/complications	0.817671809256662	34158318
immune checkpoint inhibitors/adverse effects	anti-bacterial agents/pharmacology	0.5698924731182795	34162429
gene expression regulation neoplastic	b7-h1 antigen/genetics	0.010752688172043012	33462141
immune checkpoint inhibitors/adverse effects	steroids/therapeutic use	0.817671809256662	33290513
inflammation/drug therapy	PDCD1	0.4675081813931744	32603654
immune checkpoint inhibitors/adverse effects	inflammation	0.5698924731182795	32888202
immune checkpoint inhibitors/adverse effects	prednisone/therapeutic use	0.5698924731182795	34956219
antibodies monoclonal humanized/adverse effects	immune checkpoint inhibitors/adverse effects	0.5698924731182795	34956219
immune checkpoint inhibitors/adverse effects	BTLA	0.5698924731182795	36159840
immune checkpoint inhibitors/adverse effects	CD274	0.5146397015671553	36159840
immune checkpoint inhibitors/adverse effects	CD274	0.5146397015671553	32389505
immune checkpoint inhibitors/adverse effects	CD274	0.5146397015671553	34992611
immune checkpoint inhibitors/adverse effects	CD274	0.5146397015671553	32702598
immune checkpoint inhibitors/adverse effects	CD274	0.5146397015671553	33555016
immune checkpoint inhibitors/adverse effects	CD274	0.5146397015671553	33173388
immune checkpoint inhibitors/adverse effects	CD274	0.5146397015671553	34158318
immune checkpoint inhibitors/adverse effects	CD274	0.5146397015671553	32960847
immune checkpoint inhibitors/adverse effects	CD274	0.5146397015671553	35432346
immune checkpoint inhibitors/adverse effects	CD28	0.5698924731182795	36159840
immune checkpoint inhibitors/adverse effects	CD4	0.3221131369798972	33555016
immune checkpoint inhibitors/adverse effects	CD4	0.3221131369798972	34338882
metabolome/drug effects	antineoplastic agents immunological/adverse effects	0.07526881720430108	34162429
immune checkpoint inhibitors/adverse effects	CD68	0.3221131369798972	33555016
immune checkpoint inhibitors/adverse effects	CD68	0.3221131369798972	34338882
antibodies monoclonal humanized/adverse effects	myasthenia gravis/diagnosis	0.010752688172043012	34956219
immune checkpoint inhibitors/adverse effects	CD8A	0.6321753688474461	33555016
immune checkpoint inhibitors/adverse effects	CD8A	0.6321753688474461	34338882
immune checkpoint inhibitors/adverse effects	CD8A	0.6321753688474461	34147519
immune checkpoint inhibitors/adverse effects	CSF2	0.5698924731182795	36159840
immune checkpoint inhibitors/adverse effects	CTLA4	0.5874931030514177	34992611
immune checkpoint inhibitors/adverse effects	CTLA4	0.5874931030514177	32702598
immune checkpoint inhibitors/adverse effects	CTLA4	0.5874931030514177	32603654
immune checkpoint inhibitors/adverse effects	CTLA4	0.5874931030514177	33555016
immune checkpoint inhibitors/adverse effects	CTLA4	0.5874931030514177	32567084
immune checkpoint inhibitors/adverse effects	CTLA4	0.5874931030514177	35432346
immune checkpoint inhibitors/adverse effects	CTLA4	0.5874931030514177	34147519
antibodies monoclonal humanized/adverse effects	immunosuppressive agents/therapeutic use	0.010752688172043012	34956219
metabolome/drug effects	anti-bacterial agents/pharmacology	0.010752688172043012	34162429
immune checkpoint inhibitors/adverse effects	HAVCR2	0.5698924731182795	36159840
immune checkpoint inhibitors/adverse effects	IL15	0.5698924731182795	36159840
immune checkpoint inhibitors/adverse effects	IL17C	0.5698924731182795	36159840
immune checkpoint inhibitors/adverse effects	IL21	0.5698924731182795	36159840
immune checkpoint inhibitors/adverse effects	IL22	0.817671809256662	36159840
immune checkpoint inhibitors/adverse effects	IL4	0.5698924731182795	36159840
immune checkpoint inhibitors/adverse effects	IL6	0.817671809256662	36159840
immune checkpoint inhibitors/adverse effects	LIF	0.5698924731182795	36159840
immune checkpoint inhibitors/adverse effects	PDCD1	0.9025170382516654	36159840
immune checkpoint inhibitors/adverse effects	PDCD1	0.9025170382516654	34992611
immune checkpoint inhibitors/adverse effects	PDCD1	0.9025170382516654	32702598
immune checkpoint inhibitors/adverse effects	PDCD1	0.9025170382516654	32603654
immune checkpoint inhibitors/adverse effects	PDCD1	0.9025170382516654	33555016
immune checkpoint inhibitors/adverse effects	PDCD1	0.9025170382516654	33906378
immune checkpoint inhibitors/adverse effects	PDCD1	0.9025170382516654	33173388
immune checkpoint inhibitors/adverse effects	PDCD1	0.9025170382516654	32567084
immune checkpoint inhibitors/adverse effects	PDCD1	0.9025170382516654	34158318
immune checkpoint inhibitors/adverse effects	PDCD1	0.9025170382516654	32960847
immune checkpoint inhibitors/adverse effects	PDCD1	0.9025170382516654	35432346
immune checkpoint inhibitors/adverse effects	PDCD1	0.9025170382516654	34147519
immune checkpoint inhibitors/adverse effects	SNCA	0.9238629533159688	33476895
colitis ulcerative/physiopathology	enterocolitis/chemically induced	0.021505376344086023	34821404
exanthema/chemically induced	bevacizumab/administration & dosage	0.010752688172043012	32130969
exanthema/chemically induced	pneumonia/chemically induced	0.03225806451612904	32130969
antibodies monoclonal humanized/adverse effects	skin neoplasms/immunology	0.010752688172043012	34956219
exanthema/chemically induced	fatigue/chemically induced	0.010752688172043012	32130969
exanthema/chemically induced	pruritus/chemically induced	0.010752688172043012	32130969
colon/diagnostic imaging	drug resistance/immunology	0.010752688172043012	32414860
exanthema/chemically induced	adrenal insufficiency/chemically induced	0.010752688172043012	32130969
colon/diagnostic imaging	immune checkpoint inhibitors/adverse effects	0.5698924731182795	32414860
antibodies monoclonal humanized/adverse effects	colitis/chemically induced	0.7419354838709677	34956219
exanthema/chemically induced	axitinib/administration & dosage	0.010752688172043012	32130969
gene expression regulation neoplastic	APC	0.021505376344086023	33462141
gene expression regulation neoplastic	CD274	0.16129032258064516	33462141
gene expression regulation neoplastic	CD8A	0.05376344086021506	33462141
exanthema/chemically induced	colitis/chemically induced	0.7419354838709677	32130969
exanthema/chemically induced	hypophysitis/chemically induced	0.010752688172043012	32130969
gene expression regulation neoplastic	IL17A	0.021505376344086023	33462141
antibodies monoclonal humanized/adverse effects	melanoma/immunology	0.010752688172043012	34956219
exanthema/chemically induced	angiogenesis inhibitors/therapeutic use	0.010752688172043012	32130969
colon/diagnostic imaging	skin neoplasms/drug therapy	0.021505376344086023	32414860
colon/diagnostic imaging	infliximab/adverse effects	0.04301075268817205	32414860
gene expression regulation neoplastic	MIR15B	0.010752688172043012	33462141
gene expression regulation neoplastic	NRF1	0.010752688172043012	33462141
exanthema/chemically induced	myocarditis/chemically induced	0.010752688172043012	32130969
gene expression regulation neoplastic	PDCD1	0.2688172043010753	33462141
myasthenia gravis/diagnosis	immunosuppressive agents/therapeutic use	0.010752688172043012	34956219
colitis/diagnosis	disease susceptibility	0.021505376344086023	32028372
exanthema/chemically induced	hepatitis autoimmune/etiology	0.010752688172043012	32130969
antibodies monoclonal humanized/adverse effects	immunocompromised host	0.010752688172043012	34956219
colitis/diagnosis	immune checkpoint inhibitors/pharmacology	0.08461898083216456	32298485
exanthema/chemically induced	myasthenia gravis/chemically induced	0.010752688172043012	32130969
exanthema/chemically induced	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
colitis/diagnosis	inflammatory bowel diseases	0.04277699859747545	32298485
colitis/diagnosis	postoperative complications	0.021505376344086023	32028372
lymphocytes tumor-infiltrating/metabolism	t-lymphocytes cytotoxic/immunology	0.010752688172043012	33462141
exanthema/chemically induced	ipilimumab/therapeutic use	0.03225806451612904	32130969
lymphocytes tumor-infiltrating/metabolism	tumor microenvironment/drug effects	0.010752688172043012	33462141
colitis/diagnosis	gastrointestinal tract/metabolism	0.021505376344086023	32298485
myasthenia gravis/diagnosis	skin neoplasms/immunology	0.010752688172043012	34956219
colon/diagnostic imaging	colitis/chemically induced	0.7419354838709677	32414860
colon/diagnostic imaging	glucocorticoids/pharmacology	0.010752688172043012	32414860
colitis/diagnosis	b7-h1 antigen/metabolism	0.021505376344086023	32298485
lymphocytes tumor-infiltrating/metabolism	immune checkpoint inhibitors/administration & dosage	0.04301075268817205	33462141
antibodies monoclonal humanized/adverse effects	prednisone/therapeutic use	0.010752688172043012	34956219
colitis/diagnosis	CD274	0.2980364656381486	32298485
lymphocytes tumor-infiltrating/metabolism	ht29 cells	0.010752688172043012	33462141
myasthenia gravis/diagnosis	colitis/chemically induced	0.7419354838709677	34956219
bevacizumab/administration & dosage	pneumonia/chemically induced	0.03225806451612904	32130969
lymphocytes tumor-infiltrating/metabolism	colitis/chemically induced	0.7419354838709677	33462141
bevacizumab/administration & dosage	fatigue/chemically induced	0.010752688172043012	32130969
colon/diagnostic imaging	melanoma/drug therapy	0.05376344086021506	32414860
bevacizumab/administration & dosage	pruritus/chemically induced	0.010752688172043012	32130969
colitis/diagnosis	PDCD1	0.4675081813931744	32298485
lymphocytes tumor-infiltrating/metabolism	colorectal neoplasms/drug therapy	0.010752688172043012	33462141
myasthenia gravis/diagnosis	melanoma/immunology	0.010752688172043012	34956219
bevacizumab/administration & dosage	adrenal insufficiency/chemically induced	0.010752688172043012	32130969
lymphocytes tumor-infiltrating/metabolism	b7-h1 antigen/genetics	0.010752688172043012	33462141
bevacizumab/administration & dosage	axitinib/administration & dosage	0.010752688172043012	32130969
pyrimidines/therapeutic use	immune checkpoint inhibitors/adverse effects	0.3221131369798972	33096100
pyrimidines/therapeutic use	immune checkpoint inhibitors/adverse effects	0.3221131369798972	34147519
interferon-gamma/metabolism	PDCD1	0.2688172043010753	34147519
immunosuppressive agents/therapeutic use	skin neoplasms/immunology	0.010752688172043012	34956219
myasthenia gravis/diagnosis	immunocompromised host	0.010752688172043012	34956219
mesalamine/pharmacology	colon/drug effects	0.03225806451612904	33506015
bevacizumab/administration & dosage	colitis/chemically induced	0.7419354838709677	32130969
bevacizumab/administration & dosage	hypophysitis/chemically induced	0.010752688172043012	32130969
bevacizumab/administration & dosage	angiogenesis inhibitors/therapeutic use	0.010752688172043012	32130969
immunosuppressive agents/therapeutic use	colitis/chemically induced	0.7419354838709677	34956219
bevacizumab/administration & dosage	myocarditis/chemically induced	0.010752688172043012	32130969
pyrimidines/therapeutic use	interferon-gamma/metabolism	0.021505376344086023	34147519
pyrimidines/therapeutic use	immunologic memory/drug effects	0.021505376344086023	34147519
pyrimidines/therapeutic use	colon/drug effects	0.0638148667601683	34147519
bevacizumab/administration & dosage	hepatitis autoimmune/etiology	0.010752688172043012	32130969
immunosuppressive agents/therapeutic use	melanoma/immunology	0.010752688172043012	34956219
lung neoplasms/drug therapy	CD274	0.2980364656381486	33173388
bevacizumab/administration & dosage	myasthenia gravis/chemically induced	0.010752688172043012	32130969
bevacizumab/administration & dosage	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
immunosuppressive agents/therapeutic use	immunocompromised host	0.010752688172043012	34956219
mesalamine/pharmacology	colitis/chemically induced	0.7419354838709677	33506015
myasthenia gravis/diagnosis	prednisone/therapeutic use	0.010752688172043012	34956219
bevacizumab/administration & dosage	ipilimumab/therapeutic use	0.03225806451612904	32130969
lung neoplasms/drug therapy	PDCD1	0.4675081813931744	33173388
lymphocytes tumor-infiltrating/metabolism	APC	0.021505376344086023	33462141
lymphocytes tumor-infiltrating/metabolism	CD274	0.16129032258064516	33462141
lymphocytes tumor-infiltrating/metabolism	CD8A	0.05376344086021506	33462141
immunosuppressive agents/therapeutic use	prednisone/therapeutic use	0.010752688172043012	34956219
lymphocytes tumor-infiltrating/metabolism	IL17A	0.021505376344086023	33462141
mesalamine/pharmacology	immune checkpoint inhibitors/pharmacology	0.04301075268817205	33506015
lymphocytes tumor-infiltrating/metabolism	MIR15B	0.010752688172043012	33462141
lymphocytes tumor-infiltrating/metabolism	NRF1	0.010752688172043012	33462141
diarrhea/therapy	colitis/drug therapy	0.03225806451612904	32780984
lymphocytes tumor-infiltrating/metabolism	PDCD1	0.2688172043010753	33462141
programmed cell death 1 receptor/metabolism	colitis/diagnosis	0.021505376344086023	32298485
mesalamine/pharmacology	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	33506015
mesalamine/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0.010752688172043012	33506015
diarrhea/therapy	neoplasms/therapy	0.010752688172043012	32780984
macrophages/drug effects	colon/drug effects	0.03225806451612904	34338882
ctla-4 antigen/immunology	colitis/drug therapy	0.03225806451612904	32603654
glucocorticoids	diarrhea/chemically induced	0.15053763440860218	36096534
mesalamine/pharmacology	ACAD8	0.021505376344086023	33506015
macrophages/drug effects	crohn disease/immunology	0.010752688172043012	34338882
glucocorticoids	colitis/chemically induced	0.7419354838709677	36096534
ctla-4 antigen/immunology	receptors antigen t-cell/genetics	0.010752688172043012	32603654
mesalamine/pharmacology	PDCD1	0.2688172043010753	33506015
ctla-4 antigen/immunology	t-lymphocytes regulatory/cytology	0.010752688172043012	32603654
programmed cell death 1 receptor/metabolism	immune checkpoint inhibitors/pharmacology	0.04301075268817205	32298485
immunologic memory/drug effects	colon/drug effects	0.03225806451612904	34147519
programmed cell death 1 receptor/metabolism	inflammatory bowel diseases	0.021505376344086023	32298485
macrophages/drug effects	graft vs host disease/immunology	0.010752688172043012	34338882
macrophages/drug effects	cd8-positive t-lymphocytes/drug effects	0.021505376344086023	34338882
programmed cell death 1 receptor/metabolism	gastrointestinal tract/metabolism	0.010752688172043012	32298485
macrophages/drug effects	phenotype	0.021505376344086023	34338882
ctla-4 antigen/immunology	chemokines/metabolism	0.010752688172043012	32603654
programmed cell death 1 receptor/metabolism	b7-h1 antigen/metabolism	0.010752688172043012	32298485
ctla-4 antigen/immunology	multigene family	0.010752688172043012	32603654
macrophages/drug effects	CD4	0.021505376344086023	34338882
macrophages/drug effects	CD68	0.021505376344086023	34338882
macrophages/drug effects	CD8A	0.05376344086021506	34338882
programmed cell death 1 receptor/metabolism	CD274	0.16129032258064516	32298485
programmed cell death 1 receptor/metabolism	PDCD1	0.2688172043010753	32298485
disease progression	neoplasms/drug therapy	0.12903225806451613	36377339
glucocorticoids	CHI3L1	0.010752688172043012	36096534
ctla-4 antigen/immunology	CTLA4	0.12903225806451613	32603654
squamous cell carcinoma of head and neck/drug therapy	paclitaxel/therapeutic use	0.010752688172043012	33476895
immunologic memory/drug effects	piperidines/therapeutic use	0.021505376344086023	34147519
glucocorticoids	CXCL8	0.010752688172043012	36096534
disease progression	diarrhea/chemically induced	0.15053763440860218	36377339
glucocorticoids	IL17A	0.021505376344086023	36096534
glucocorticoids	IL6	0.021505376344086023	36096534
squamous cell carcinoma of head and neck/drug therapy	colitis ulcerative/chemically induced	0.010752688172043012	33476895
immunologic memory/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	34147519
disease progression	colitis/chemically induced	0.7419354838709677	36377339
ctla-4 antigen/immunology	PDCD1	0.2688172043010753	32603654
disease progression	abdominal pain/chemically induced	0.010752688172043012	36377339
pneumonia/chemically induced	fatigue/chemically induced	0.03225806451612903	32130969
interferon-gamma/metabolism	immunologic memory/drug effects	0.010752688172043012	34147519
immunologic memory/drug effects	ctla-4 antigen/antagonists & inhibitors	0.03225806451612904	34147519
squamous cell carcinoma of head and neck/drug therapy	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	33476895
interferon-gamma/metabolism	colon/drug effects	0.03225806451612904	34147519
pneumonia/chemically induced	immune checkpoint inhibitors	0.6939799331103678	35124713
pneumonia/chemically induced	pruritus/chemically induced	0.03225806451612903	32130969
pneumonia/chemically induced	antibodies monoclonal humanized/administration & dosage	0.03225806451612903	32540858
squamous cell carcinoma of head and neck/drug therapy	antineoplastic agents immunological/adverse effects	0.07526881720430108	33476895
immunologic memory/drug effects	cd8-positive t-lymphocytes/drug effects	0.021505376344086023	34147519
disease progression	antineoplastic agents immunological/therapeutic use	0.03225806451612904	36377339
immunologic memory/drug effects	phenotype	0.021505376344086023	34147519
axitinib/administration & dosage	colitis/chemically induced	0.7419354838709677	32130969
axitinib/administration & dosage	hypophysitis/chemically induced	0.010752688172043012	32130969
pneumonia/chemically induced	adrenal insufficiency/chemically induced	0.03225806451612903	32130969
pneumonia/chemically induced	carcinoma non-small-cell lung/drug therapy	0.0638148667601683	35124713
axitinib/administration & dosage	angiogenesis inhibitors/therapeutic use	0.010752688172043012	32130969
pneumonia/chemically induced	axitinib/administration & dosage	0.03225806451612903	32130969
axitinib/administration & dosage	myocarditis/chemically induced	0.010752688172043012	32130969
immunologic memory/drug effects	CD8A	0.05376344086021506	34147519
squamous cell carcinoma of head and neck/drug therapy	SNCA	0.03225806451612904	33476895
axitinib/administration & dosage	hepatitis autoimmune/etiology	0.010752688172043012	32130969
immunologic memory/drug effects	CTLA4	0.12903225806451613	34147519
disease progression	gastritis/complications	0.010752688172043012	36377339
pneumonia/chemically induced	immune checkpoint inhibitors/administration & dosage	0.12485550914723424	32540858
axitinib/administration & dosage	myasthenia gravis/chemically induced	0.010752688172043012	32130969
disease progression	enterocolitis/chemically induced	0.021505376344086023	36377339
axitinib/administration & dosage	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
pneumonia/chemically induced	colitis/chemically induced	0.4037575327897907	35124713
pneumonia/chemically induced	colitis/chemically induced	0.4037575327897907	32540858
pneumonia/chemically induced	colitis/chemically induced	0.4037575327897907	32130969
immunologic memory/drug effects	PDCD1	0.2688172043010753	34147519
pneumonia/chemically induced	hypophysitis/chemically induced	0.03225806451612903	32130969
tongue neoplasms/drug therapy	paclitaxel/therapeutic use	0.010752688172043012	33476895
pneumonia/chemically induced	angiogenesis inhibitors/therapeutic use	0.03225806451612903	32130969
axitinib/administration & dosage	ipilimumab/therapeutic use	0.03225806451612904	32130969
interferon-gamma/metabolism	piperidines/therapeutic use	0.021505376344086023	34147519
pruritus/chemically induced	adrenal insufficiency/chemically induced	0.010752688172043012	32130969
pneumonia/chemically induced	myocarditis/chemically induced	0.03225806451612903	32130969
tongue neoplasms/drug therapy	colitis ulcerative/chemically induced	0.010752688172043012	33476895
pruritus/chemically induced	axitinib/administration & dosage	0.010752688172043012	32130969
interferon-gamma/metabolism	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	34147519
pneumonia/chemically induced	hepatitis autoimmune/etiology	0.03225806451612903	32130969
tongue neoplasms/drug therapy	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	33476895
interferon-gamma/metabolism	ctla-4 antigen/antagonists & inhibitors	0.03225806451612904	34147519
pneumonia/chemically induced	dose-response relationship drug	0.0638148667601683	32540858
pneumonia/chemically induced	myasthenia gravis/chemically induced	0.03225806451612903	32130969
pneumonia/chemically induced	immune checkpoint inhibitors/therapeutic use	0.0638148667601683	32130969
tongue neoplasms/drug therapy	antineoplastic agents immunological/adverse effects	0.07526881720430108	33476895
pneumonia/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.23886071852411256	32540858
pruritus/chemically induced	colitis/chemically induced	0.7419354838709677	32130969
tumor microenvironment/drug effects	immune checkpoint inhibitors/administration & dosage	0.04301075268817205	33462141
pruritus/chemically induced	hypophysitis/chemically induced	0.010752688172043012	32130969
tumor microenvironment/drug effects	ht29 cells	0.010752688172043012	33462141
tumor microenvironment/drug effects	colitis/chemically induced	0.7419354838709677	33462141
interferon-gamma/metabolism	cd8-positive t-lymphocytes/drug effects	0.021505376344086023	34147519
pruritus/chemically induced	angiogenesis inhibitors/therapeutic use	0.010752688172043012	32130969
interferon-gamma/metabolism	phenotype	0.021505376344086023	34147519
tumor microenvironment/drug effects	colorectal neoplasms/drug therapy	0.010752688172043012	33462141
tumor necrosis factor inhibitors	diarrhea/chemically induced	0.15053763440860218	32641348
pruritus/chemically induced	myocarditis/chemically induced	0.010752688172043012	32130969
pneumonia/chemically induced	ipilimumab/therapeutic use	0.0020883744586409386	35124713
pneumonia/chemically induced	ipilimumab/therapeutic use	0.0020883744586409386	32130969
tumor microenvironment/drug effects	b7-h1 antigen/genetics	0.010752688172043012	33462141
pneumonia/chemically induced	drugs investigational/administration & dosage	0.03225806451612903	32540858
tongue neoplasms/drug therapy	SNCA	0.03225806451612904	33476895
interferon-gamma/metabolism	CD8A	0.05376344086021506	34147519
pruritus/chemically induced	hepatitis autoimmune/etiology	0.010752688172043012	32130969
tumor necrosis factor inhibitors	colitis/chemically induced	0.7419354838709677	32641348
interferon-gamma/metabolism	CTLA4	0.12903225806451613	34147519
adrenal insufficiency/chemically induced	axitinib/administration & dosage	0.010752688172043012	32130969
pruritus/chemically induced	myasthenia gravis/chemically induced	0.010752688172043012	32130969
pneumonia/chemically induced	CD274	0.41374474053295934	32540858
pruritus/chemically induced	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
feces	diarrhea/chemically induced	0.15053763440860218	33290513
adrenal insufficiency/chemically induced	colitis/chemically induced	0.7419354838709677	32130969
feces	colitis/chemically induced	0.7419354838709677	33290513
adrenal insufficiency/chemically induced	hypophysitis/chemically induced	0.010752688172043012	32130969
tumor necrosis factor inhibitors	melanoma/drug therapy	0.05376344086021506	32641348
pneumonia/chemically induced	PDCD1	0.6137971425488957	32540858
tumor microenvironment/drug effects	APC	0.021505376344086023	33462141
adrenal insufficiency/chemically induced	angiogenesis inhibitors/therapeutic use	0.010752688172043012	32130969
tumor microenvironment/drug effects	CD274	0.16129032258064516	33462141
pruritus/chemically induced	ipilimumab/therapeutic use	0.03225806451612904	32130969
tumor microenvironment/drug effects	CD8A	0.05376344086021506	33462141
adrenal insufficiency/chemically induced	myocarditis/chemically induced	0.010752688172043012	32130969
tumor microenvironment/drug effects	IL17A	0.021505376344086023	33462141
adrenal insufficiency/chemically induced	hepatitis autoimmune/etiology	0.010752688172043012	32130969
ipilimumab/adverse effects	CTLA4	0.08887240280676237	35191192
ipilimumab/adverse effects	CTLA4	0.08887240280676237	32934876
ipilimumab/adverse effects	CTLA4	0.08887240280676237	35917654
tumor microenvironment/drug effects	MIR15B	0.010752688172043012	33462141
tumor microenvironment/drug effects	NRF1	0.010752688172043012	33462141
adrenal insufficiency/chemically induced	myasthenia gravis/chemically induced	0.010752688172043012	32130969
tumor microenvironment/drug effects	PDCD1	0.2688172043010753	33462141
adrenal insufficiency/chemically induced	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
feces	dose-response relationship drug	0.021505376344086023	33290513
ipilimumab/adverse effects	PDCD1	0.7566317442271808	35191192
ipilimumab/adverse effects	PDCD1	0.7566317442271808	35917654
ipilimumab/adverse effects	SNCA	0.26572445787032045	32934876
b7-h1 antigen/antagonists & inhibitors	colitis/chemically induced	0.837646224742999	32389505
b7-h1 antigen/antagonists & inhibitors	colitis/chemically induced	0.837646224742999	32702598
adrenal insufficiency/chemically induced	ipilimumab/therapeutic use	0.03225806451612904	32130969
b7-h1 antigen/antagonists & inhibitors	neoplasms/complications	0.09467811291093199	32960847
b7-h1 antigen/antagonists & inhibitors	biomarkers/metabolism	0.03225806451612903	32389505
encephalitis/diagnostic imaging	colitis/diagnostic imaging	0.010752688172043012	33375984
b7-h1 antigen/antagonists & inhibitors	programmed cell death 1 receptor/antagonists & inhibitors	0.018772251591325922	32702598
b7-h1 antigen/antagonists & inhibitors	programmed cell death 1 receptor/antagonists & inhibitors	0.018772251591325922	32960847
feces	steroids/therapeutic use	0.021505376344086023	33290513
b7-h1 antigen/antagonists & inhibitors	adenocarcinoma of lung/drug therapy	0.03225806451612903	32389505
b7-h1 antigen/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.09467811291093199	32702598
tumor necrosis factor inhibitors	SNCA	0.03225806451612904	32641348
tumor necrosis factor inhibitors	TNF	0.03225806451612904	32641348
b7-h1 antigen/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.2113496601575143	32702598
antibodies monoclonal humanized/administration & dosage	immune checkpoint inhibitors/administration & dosage	0.04301075268817205	32540858
carcinoma non-small-cell lung/drug therapy	colitis/chemically induced	0.5483870967741937	35124713
carcinoma non-small-cell lung/drug therapy	colitis/chemically induced	0.5483870967741937	34992611
antibodies monoclonal humanized/administration & dosage	colitis/chemically induced	0.7419354838709677	32540858
colitis	inflammatory bowel diseases/drug therapy	0.12485550914723427	33314269
b7-h1 antigen/antagonists & inhibitors	CD274	0.003506311360448808	32389505
b7-h1 antigen/antagonists & inhibitors	CD274	0.003506311360448808	32702598
b7-h1 antigen/antagonists & inhibitors	CD274	0.003506311360448808	32960847
colitis	recurrence	0.04301075268817204	35842365
b7-h1 antigen/antagonists & inhibitors	CTLA4	0.3425088235747422	32702598
encephalitis/diagnostic imaging	pneumonia/diagnostic imaging	0.010752688172043012	33375984
b7-h1 antigen/antagonists & inhibitors	PDCD1	0.1749302590817317	32702598
b7-h1 antigen/antagonists & inhibitors	PDCD1	0.1749302590817317	32960847
inflammatory bowel diseases/drug therapy	proton pump inhibitors/adverse effects	0.03225806451612903	35277350
antibodies monoclonal humanized/administration & dosage	dose-response relationship drug	0.021505376344086023	32540858
carcinoma non-small-cell lung/drug therapy	ipilimumab/therapeutic use	0.0638148667601683	35124713
inflammatory bowel diseases/drug therapy	colitis/chemically induced	0.837646224742999	33555016
inflammatory bowel diseases/drug therapy	colitis/chemically induced	0.837646224742999	35277350
antibodies monoclonal humanized/administration & dosage	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	32540858
carcinoma non-small-cell lung/drug therapy	CD274	0.2980364656381486	34992611
carcinoma non-small-cell lung/drug therapy	CTLA4	0.24263674614305747	34992611
colitis	inflammatory bowel diseases	0.08461898083216456	35842365
carcinoma non-small-cell lung/drug therapy	PDCD1	0.4675081813931744	34992611
immune checkpoint inhibitors/administration & dosage	ht29 cells	0.04301075268817204	33462141
antibodies monoclonal humanized/administration & dosage	drugs investigational/administration & dosage	0.010752688172043012	32540858
immune checkpoint inhibitors/administration & dosage	colitis/chemically induced	0.2960888573791799	33495297
immune checkpoint inhibitors/administration & dosage	colitis/chemically induced	0.2960888573791799	32540858
immune checkpoint inhibitors/administration & dosage	colitis/chemically induced	0.2960888573791799	32418993
immune checkpoint inhibitors/administration & dosage	colitis/chemically induced	0.2960888573791799	33462141
immune checkpoint inhibitors/administration & dosage	phthalazines/administration & dosage	0.04301075268817204	33495297
colitis	ligands	0.04301075268817204	35432346
immune checkpoint inhibitors/administration & dosage	dextran sulfate/adverse effects	0.04301075268817204	33495297
azoxymethane/adverse effects	immune checkpoint inhibitors/administration & dosage	0.04301075268817205	33495297
inflammatory bowel diseases/drug therapy	ipilimumab/therapeutic use	0.09467811291093199	35277350
immune checkpoint inhibitors/administration & dosage	colorectal neoplasms/drug therapy	0.04301075268817204	33462141
antibodies monoclonal humanized/administration & dosage	CD274	0.16129032258064516	32540858
azoxymethane/adverse effects	colitis/chemically induced	0.7419354838709677	33495297
azoxymethane/adverse effects	phthalazines/administration & dosage	0.010752688172043012	33495297
immune checkpoint inhibitors/administration & dosage	carcinoma non-small-cell lung/complications	0.04301075268817204	32418993
azoxymethane/adverse effects	dextran sulfate/adverse effects	0.010752688172043012	33495297
immune checkpoint inhibitors/administration & dosage	b7-h1 antigen/genetics	0.04301075268817204	33462141
immune checkpoint inhibitors/administration & dosage	colonic neoplasms/drug therapy	0.04301075268817204	33495297
inflammatory bowel diseases/drug therapy	CD274	0.06661991584852735	33555016
inflammatory bowel diseases/drug therapy	CD274	0.06661991584852735	33314269
inflammatory bowel diseases/drug therapy	CD4	0.0638148667601683	33555016
inflammatory bowel diseases/drug therapy	CD68	0.0638148667601683	33555016
inflammatory bowel diseases/drug therapy	CD8A	0.15435476164788925	33555016
colitis microscopic/chemically induced	inflammatory bowel diseases/complications	0.04277699859747545	32401685
azoxymethane/adverse effects	colonic neoplasms/drug therapy	0.010752688172043012	33495297
inflammatory bowel diseases/drug therapy	CTLA4	0.042892591279688044	33555016
inflammatory bowel diseases/drug therapy	CTLA4	0.042892591279688044	33314269
antibodies monoclonal humanized/administration & dosage	PDCD1	0.2688172043010753	32540858
immune checkpoint inhibitors/administration & dosage	dose-response relationship drug	0.08461898083216456	32540858
inflammatory bowel diseases/drug therapy	PDCD1	0.1749302590817317	33555016
inflammatory bowel diseases/drug therapy	PDCD1	0.1749302590817317	33314269
skin neoplasms/drug therapy	infliximab/adverse effects	0.08461898083216456	32414860
antibodies monoclonal humanized/therapeutic use	steroids/adverse effects	0.010752688172043012	33454238
azoxymethane/adverse effects	cell line tumor	0.021505376344086023	33495297
colitis	CD274	0.12061711079943897	35432346
colitis	CD274	0.12061711079943897	33314269
skin neoplasms/drug therapy	tumor necrosis factor inhibitors	0.021505376344086023	32641348
immune checkpoint inhibitors/administration & dosage	programmed cell death 1 receptor/antagonists & inhibitors	0.30651754354419153	32540858
immune checkpoint inhibitors/administration & dosage	drug-related side effects and adverse reactions	0.08461898083216456	32418993
azoxymethane/adverse effects	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010752688172043012	33495297
immune checkpoint inhibitors/administration & dosage	melanoma/complications	0.12485550914723427	32418993
immune checkpoint inhibitors/administration & dosage	cell line tumor	0.08461898083216456	33495297
colitis	CTLA4	0.0795123530046391	35432346
colitis	CTLA4	0.0795123530046391	33314269
antibodies monoclonal humanized/therapeutic use	colitis/chemically induced	0.7419354838709677	33454238
immune checkpoint inhibitors/administration & dosage	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.04301075268817204	33495297
colitis microscopic/chemically induced	PDCD1	0.4675081813931744	32401685
immune checkpoint inhibitors/administration & dosage	infliximab/administration & dosage	0.04301075268817204	32418993
azoxymethane/adverse effects	piperazines/administration & dosage	0.010752688172043012	33495297
colitis/drug therapy	diarrhea/chemically induced	0.3906030855539973	33436487
azoxymethane/adverse effects	APC	0.021505376344086023	33495297
skin neoplasms/drug therapy	diarrhea/chemically induced	0.27980364656381496	32641348
colitis	PDCD1	0.29196142800630875	35432346
colitis	PDCD1	0.29196142800630875	33314269
azoxymethane/adverse effects	ARG1	0.010752688172043012	33495297
immune checkpoint inhibitors/administration & dosage	drugs investigational/administration & dosage	0.04301075268817204	32540858
colitis/drug therapy	neoplasms/therapy	0.03225806451612903	32780984
skin neoplasms/drug therapy	colitis/chemically induced	0.5483870967741937	32414860
skin neoplasms/drug therapy	colitis/chemically induced	0.5483870967741937	32641348
immune checkpoint inhibitors/administration & dosage	piperazines/administration & dosage	0.04301075268817204	33495297
azoxymethane/adverse effects	PARP1	0.010752688172043012	33495297
azoxymethane/adverse effects	PDCD1	0.2688172043010753	33495297
skin neoplasms/drug therapy	glucocorticoids/pharmacology	0.021505376344086023	32414860
azoxymethane/adverse effects	TIPARP	0.010752688172043012	33495297
immune checkpoint inhibitors/administration & dosage	ACAD8	0.08461898083216456	32418993
colitis/drug therapy	receptors antigen t-cell/genetics	0.03225806451612903	32603654
immune checkpoint inhibitors/administration & dosage	APC	0.001402524544179523	33495297
immune checkpoint inhibitors/administration & dosage	APC	0.001402524544179523	33462141
immune checkpoint inhibitors/administration & dosage	ARG1	0.04301075268817204	33495297
immune checkpoint inhibitors/administration & dosage	CD274	0.12061711079943897	32540858
immune checkpoint inhibitors/administration & dosage	CD274	0.12061711079943897	33462141
immune checkpoint inhibitors/administration & dosage	CD8A	0.20133505266745094	33462141
immune checkpoint inhibitors/administration & dosage	CRP	0.04301075268817204	32418993
colitis/drug therapy	t-lymphocytes regulatory/cytology	0.03225806451612903	32603654
gentian violet	colitis/chemically induced	0.7419354838709677	32888202
colitis/drug therapy	feces/chemistry	0.03225806451612903	33436487
gastritis/chemically induced	colitis/chemically induced	0.7419354838709677	32621258
immune checkpoint inhibitors/administration & dosage	IL17A	0.08461898083216456	33462141
skin neoplasms/drug therapy	melanoma/drug therapy	0.0023375409069658717	32414860
skin neoplasms/drug therapy	melanoma/drug therapy	0.0023375409069658717	32641348
immune checkpoint inhibitors/administration & dosage	MIR15B	0.04301075268817204	33462141
immune checkpoint inhibitors/administration & dosage	NRF1	0.04301075268817204	33462141
immune checkpoint inhibitors/administration & dosage	PARP1	0.04301075268817204	33495297
immune checkpoint inhibitors/administration & dosage	PDCD1	0.05789909015715467	33495297
immune checkpoint inhibitors/administration & dosage	PDCD1	0.05789909015715467	32540858
immune checkpoint inhibitors/administration & dosage	PDCD1	0.05789909015715467	33462141
immune checkpoint inhibitors/administration & dosage	TIPARP	0.04301075268817204	33495297
colitis/drug therapy	leukocyte l1 antigen complex/analysis	0.03225806451612903	33436487
skin neoplasms/drug therapy	immunosuppressive agents/pharmacology	0.021505376344086023	32414860
dysbiosis/etiology	neoplasms/complications	0.03225806451612904	34162429
colitis/drug therapy	chemokines/metabolism	0.03225806451612903	32603654
colitis/drug therapy	multigene family	0.03225806451612903	32603654
skin neoplasms/drug therapy	mucositis/chemically induced	0.021505376344086023	32414860
skin neoplasms/immunology	colitis/chemically induced	0.7419354838709677	34956219
colitis/drug therapy	biomarkers/analysis	0.03225806451612903	33436487
skin neoplasms/immunology	melanoma/immunology	0.010752688172043012	34956219
gentian violet	inflammation	0.010752688172043012	32888202
skin neoplasms/immunology	immunocompromised host	0.010752688172043012	34956219
dysbiosis/etiology	colitis/etiology	0.021505376344086023	34162429
t-lymphocytes cytotoxic/immunology	tumor microenvironment/drug effects	0.010752688172043012	33462141
colitis/drug therapy	CTLA4	0.3425088235747422	32603654
t-lymphocytes cytotoxic/immunology	immune checkpoint inhibitors/administration & dosage	0.04301075268817205	33462141
t-lymphocytes cytotoxic/immunology	ht29 cells	0.010752688172043012	33462141
t-lymphocytes cytotoxic/immunology	colitis/chemically induced	0.7419354838709677	33462141
skin neoplasms/immunology	prednisone/therapeutic use	0.010752688172043012	34956219
colitis/drug therapy	PDCD1	0.6137971425488957	32603654
skin neoplasms/drug therapy	SNCA	0.0638148667601683	32641348
skin neoplasms/drug therapy	TNF	0.0638148667601683	32641348
dysbiosis/etiology	antineoplastic agents immunological/adverse effects	0.07526881720430108	34162429
t-lymphocytes cytotoxic/immunology	colorectal neoplasms/drug therapy	0.010752688172043012	33462141
t-lymphocytes cytotoxic/immunology	b7-h1 antigen/genetics	0.010752688172043012	33462141
dysbiosis/etiology	anti-bacterial agents/pharmacology	0.010752688172043012	34162429
steroids/adverse effects	colitis/chemically induced	0.7419354838709677	33454238
protein kinase inhibitors/therapeutic use	neoplasms/drug therapy	0.12903225806451613	33096100
colon/drug effects	colitis/chemically induced	0.9844026940801134	33506015
colon/drug effects	crohn disease/immunology	0.03225806451612903	34338882
recurrence	inflammatory bowel diseases	0.021505376344086023	35842365
protein kinase inhibitors/therapeutic use	ipilimumab/adverse effects	0.0967741935483871	33096100
t-lymphocytes cytotoxic/immunology	APC	0.021505376344086023	33462141
t-lymphocytes cytotoxic/immunology	CD274	0.16129032258064516	33462141
clostridium infections/chemically induced	colitis/chemically induced	0.7419354838709677	34107499
t-lymphocytes cytotoxic/immunology	CD8A	0.05376344086021506	33462141
protein kinase inhibitors/therapeutic use	colitis/chemically induced	0.7419354838709677	33096100
t-lymphocytes cytotoxic/immunology	IL17A	0.021505376344086023	33462141
t-lymphocytes cytotoxic/immunology	MIR15B	0.010752688172043012	33462141
t-lymphocytes cytotoxic/immunology	NRF1	0.010752688172043012	33462141
t-lymphocytes cytotoxic/immunology	PDCD1	0.2688172043010753	33462141
clostridium infections/chemically induced	anti-bacterial agents/adverse effects	0.010752688172043012	34107499
colon/drug effects	immune checkpoint inhibitors/pharmacology	0.12485550914723424	33506015
colon/drug effects	piperidines/therapeutic use	0.0638148667601683	34147519
hepatitis/diagnostic imaging	pericarditis/diagnostic imaging	0.010752688172043012	33375984
hepatitis/diagnostic imaging	encephalitis/diagnostic imaging	0.010752688172043012	33375984
colon/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.018772251591325922	33506015
colon/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.018772251591325922	34147519
protein kinase inhibitors/therapeutic use	piperidines/therapeutic use	0.021505376344086023	33096100
colon/drug effects	trinitrobenzenesulfonic acid/adverse effects	0.03225806451612903	33506015
colon/drug effects	ctla-4 antigen/antagonists & inhibitors	0.09467811291093199	34147519
hepatitis/diagnostic imaging	colitis/diagnostic imaging	0.010752688172043012	33375984
colon/drug effects	graft vs host disease/immunology	0.03225806451612903	34338882
lymphocytes/drug effects	colitis/chemically induced	0.7419354838709677	32567084
colon/drug effects	cd8-positive t-lymphocytes/drug effects	0.0007012622720897616	34338882
colon/drug effects	cd8-positive t-lymphocytes/drug effects	0.0007012622720897616	34147519
colon/drug effects	phenotype	0.0007012622720897616	34338882
colon/drug effects	phenotype	0.0007012622720897616	34147519
lymphocytes/drug effects	vitamin d/administration & dosage	0.010752688172043012	32567084
colon/drug effects	ACAD8	0.0638148667601683	33506015
hepatitis/diagnostic imaging	pneumonia/diagnostic imaging	0.010752688172043012	33375984
colon/drug effects	CD4	0.0638148667601683	34338882
lymphocytes/drug effects	neutrophils/drug effects	0.010752688172043012	32567084
colon/drug effects	CD68	0.0638148667601683	34338882
lymphocytes/drug effects	antibodies monoclonal/adverse effects	0.010752688172043012	32567084
colon/drug effects	CD8A	0.006858499144614151	34338882
colon/drug effects	CD8A	0.006858499144614151	34147519
lymphocytes/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	32567084
colon/drug effects	CTLA4	0.3425088235747422	34147519
lymphocytes/drug effects	melanoma/complications	0.03225806451612904	32567084
lymphocytes/drug effects	ctla-4 antigen/antagonists & inhibitors	0.03225806451612904	32567084
lymphocytes/drug effects	antineoplastic agents immunological/adverse effects	0.07526881720430108	32567084
colon/drug effects	PDCD1	0.1749302590817317	33506015
colon/drug effects	PDCD1	0.1749302590817317	34147519
chemical and drug induced liver injury/diagnosis	neoplasms/drug therapy	0.12903225806451613	33080231
lymphocytes/drug effects	CTLA4	0.12903225806451613	32567084
colitis/epidemiology	b7-h1 antigen/antagonists & inhibitors	0.03225806451612904	32960847
chemical and drug induced liver injury/diagnosis	colitis/chemically induced	0.7419354838709677	33080231
infliximab/adverse effects	antibodies monoclonal humanized/therapeutic use	0.04301075268817204	33454238
infliximab/adverse effects	steroids/adverse effects	0.04301075268817204	33454238
lymphocytes/drug effects	PDCD1	0.2688172043010753	32567084
neoplasms/drug therapy	colitis/drug therapy	0.34250882357474227	33436487
infliximab/adverse effects	diarrhea/chemically induced	0.4853981611344865	32584703
growth inhibitors/therapeutic use	phosphatidylinositol 3-kinases/metabolism	0.010752688172043012	34987517
neoplasms/drug therapy	diarrhea/chemically induced	0.016131479167785994	31609734
neoplasms/drug therapy	diarrhea/chemically induced	0.016131479167785994	33436487
neoplasms/drug therapy	diarrhea/chemically induced	0.016131479167785994	34107499
neoplasms/drug therapy	diarrhea/chemically induced	0.016131479167785994	34380976
neoplasms/drug therapy	diarrhea/chemically induced	0.016131479167785994	36377339
crohn disease/physiopathology	enterocolitis/chemically induced	0.021505376344086023	34821404
neoplasms/drug therapy	ipilimumab/adverse effects	0.7287605378574964	33096100
growth inhibitors/therapeutic use	antineoplastic agents immunological/therapeutic use	0.03225806451612904	34987517
neoplasms/drug therapy	clostridium infections/chemically induced	0.12903225806451613	34107499
growth inhibitors/therapeutic use	lymphocytes tumor-infiltrating/immunology	0.010752688172043012	34987517
neoplasms/drug therapy	colitis/chemically induced	0.1262339843735465	33741313
neoplasms/drug therapy	colitis/chemically induced	0.1262339843735465	33096100
neoplasms/drug therapy	colitis/chemically induced	0.1262339843735465	31609734
neoplasms/drug therapy	colitis/chemically induced	0.1262339843735465	33080231
neoplasms/drug therapy	colitis/chemically induced	0.1262339843735465	35236743
neoplasms/drug therapy	colitis/chemically induced	0.1262339843735465	33459466
neoplasms/drug therapy	colitis/chemically induced	0.1262339843735465	34777387
neoplasms/drug therapy	colitis/chemically induced	0.1262339843735465	34107499
neoplasms/drug therapy	colitis/chemically induced	0.1262339843735465	34380976
neoplasms/drug therapy	colitis/chemically induced	0.1262339843735465	32185493
neoplasms/drug therapy	colitis/chemically induced	0.1262339843735465	36377339
infliximab/adverse effects	colitis/chemically induced	0.2960888573791799	32162824
infliximab/adverse effects	colitis/chemically induced	0.2960888573791799	32414860
infliximab/adverse effects	colitis/chemically induced	0.2960888573791799	33454238
infliximab/adverse effects	colitis/chemically induced	0.2960888573791799	32584703
neoplasms/drug therapy	abdominal pain/chemically induced	0.12903225806451613	36377339
colitis/epidemiology	neoplasms/complications	0.03225806451612904	32960847
infliximab/adverse effects	glucocorticoids/pharmacology	0.04301075268817204	32414860
growth inhibitors/therapeutic use	colitis/etiology	0.021505376344086023	34987517
neoplasms/drug therapy	anti-bacterial agents/adverse effects	0.12903225806451613	34107499
growth inhibitors/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	34987517
growth inhibitors/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	34987517
neoplasms/drug therapy	intestinal mucosa/immunology	0.12903225806451613	33459466
neoplasms/drug therapy	feces/chemistry	0.12903225806451613	33436487
growth inhibitors/therapeutic use	cell line tumor	0.021505376344086023	34987517
neoplasms/drug therapy	antineoplastic agents immunological/therapeutic use	0.34250882357474227	36377339
neoplasms/drug therapy	immune checkpoint inhibitors/pharmacology	0.43017431376477666	35236743
neoplasms/drug therapy	piperidines/therapeutic use	0.2426367461430575	33096100
neoplasms/drug therapy	colon/immunology	0.015427769985974752	33459466
neoplasms/drug therapy	colon/immunology	0.015427769985974752	34777387
infliximab/adverse effects	melanoma/drug therapy	0.013413888589204155	32162824
infliximab/adverse effects	melanoma/drug therapy	0.013413888589204155	32414860
growth inhibitors/therapeutic use	cd8-positive t-lymphocytes/immunology	0.010752688172043012	34987517
neoplasms/drug therapy	leukocyte l1 antigen complex/analysis	0.12903225806451613	33436487
neoplasms/drug therapy	t-lymphocyte subsets/immunology	0.12903225806451613	34777387
infliximab/adverse effects	immunosuppressive agents/pharmacology	0.04301075268817204	32414860
colitis/epidemiology	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	32960847
neoplasms/drug therapy	gastritis/complications	0.12903225806451613	36377339
phthalazines/administration & dosage	cell line tumor	0.021505376344086023	33495297
diarrhea/chemically induced	ipilimumab/adverse effects	0.4062869550880755	31595568
diarrhea/chemically induced	ipilimumab/adverse effects	0.4062869550880755	35917654
neoplasms/drug therapy	biological products/therapeutic use	0.12903225806451613	34380976
infliximab/adverse effects	drug-related side effects and adverse reactions	0.08461898083216456	32162824
neoplasms/drug therapy	enterocolitis/chemically induced	0.2426367461430575	36377339
growth inhibitors/therapeutic use	cytotoxicity immunologic	0.010752688172043012	34987517
diarrhea/chemically induced	clostridium infections/chemically induced	0.15053763440860216	34107499
phthalazines/administration & dosage	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010752688172043012	33495297
neoplasms/drug therapy	hepatitis/diagnosis	0.12903225806451613	32185493
neoplasms/drug therapy	biomarkers/analysis	0.12903225806451613	33436487
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	32641348
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	31609734
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	36113896
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	34107499
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	33173388
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	34158318
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	34380976
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	33290513
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	31595568
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	35917654
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	36096534
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	36377339
diarrhea/chemically induced	colitis/chemically induced	0.07296491852068898	32584703
infliximab/adverse effects	mucositis/chemically induced	0.04301075268817204	32414860
neoplasms/drug therapy	butyrates/metabolism	0.12903225806451613	33741313
diarrhea/chemically induced	neoplasms/complications	0.3906030855539973	34158318
growth inhibitors/therapeutic use	CD8A	0.05376344086021506	34987517
diarrhea/chemically induced	abdominal pain/chemically induced	0.15053763440860216	36377339
neoplasms/drug therapy	AHR	0.12903225806451613	35236743
phthalazines/administration & dosage	piperazines/administration & dosage	0.010752688172043012	33495297
phthalazines/administration & dosage	APC	0.021505376344086023	33495297
phthalazines/administration & dosage	ARG1	0.010752688172043012	33495297
diarrhea/chemically induced	anti-bacterial agents/adverse effects	0.15053763440860216	34107499
neoplasms/drug therapy	IL22	0.2426367461430575	35236743
growth inhibitors/therapeutic use	MTOR	0.010752688172043012	34987517
growth inhibitors/therapeutic use	PDCD1	0.2688172043010753	34987517
phthalazines/administration & dosage	PARP1	0.010752688172043012	33495297
phthalazines/administration & dosage	PDCD1	0.2688172043010753	33495297
diarrhea/chemically induced	feces/chemistry	0.15053763440860216	33436487
colitis/epidemiology	CD274	0.16129032258064516	32960847
diarrhea/chemically induced	melanoma/drug therapy	0.5663467650009717	32641348
phthalazines/administration & dosage	TIPARP	0.010752688172043012	33495297
ht29 cells	colitis/chemically induced	0.7419354838709677	33462141
diarrhea/chemically induced	antineoplastic agents immunological/therapeutic use	0.3906030855539973	36377339
diarrhea/chemically induced	dose-response relationship drug	0.27980364656381485	33290513
ht29 cells	colorectal neoplasms/drug therapy	0.010752688172043012	33462141
diarrhea/chemically induced	leukocyte l1 antigen complex/analysis	0.15053763440860216	33436487
ht29 cells	b7-h1 antigen/genetics	0.010752688172043012	33462141
infliximab/adverse effects	LTF	0.04301075268817204	32584703
colitis/epidemiology	PDCD1	0.2688172043010753	32960847
neoplasms/complications	colitis/etiology	0.0638148667601683	34162429
infliximab/adverse effects	TNF	0.12485550914723427	32162824
neoplasms/complications	programmed cell death 1 receptor/antagonists & inhibitors	0.23886071852411256	32960847
diarrhea/chemically induced	gastritis/complications	0.15053763440860216	36377339
sarcoidosis/diagnostic imaging	hepatitis/diagnostic imaging	0.010752688172043012	33375984
diarrhea/chemically induced	biological products/therapeutic use	0.15053763440860216	34380976
diarrhea/chemically induced	enterocolitis/chemically induced	0.27980364656381485	36377339
diarrhea/chemically induced	beclomethasone/adverse effects	0.15053763440860216	36113896
biomarkers/metabolism	adenocarcinoma of lung/drug therapy	0.010752688172043012	32389505
neoplasms/complications	antineoplastic agents immunological/adverse effects	0.2113496601575143	34162429
diarrhea/chemically induced	biomarkers/analysis	0.15053763440860216	33436487
neoplasms/complications	inflammatory bowel diseases/complications	0.0638148667601683	34158318
sarcoidosis/diagnostic imaging	pericarditis/diagnostic imaging	0.010752688172043012	33375984
neoplasms/complications	anti-bacterial agents/pharmacology	0.03225806451612903	34162429
sarcoidosis/diagnostic imaging	encephalitis/diagnostic imaging	0.010752688172043012	33375984
diarrhea/chemically induced	inflammatory bowel diseases/complications	0.27980364656381485	34158318
neoplasms/complications	CD274	0.06661991584852735	34158318
neoplasms/complications	CD274	0.06661991584852735	32960847
lung neoplasms/drug therapy	diarrhea/chemically induced	0.27980364656381496	33173388
diarrhea/chemically induced	steroids/therapeutic use	0.27980364656381485	33290513
biomarkers/metabolism	CD274	0.16129032258064516	32389505
diarrhea/chemically induced	CD274	0.4005277521603798	35917654
diarrhea/chemically induced	CD274	0.4005277521603798	33173388
diarrhea/chemically induced	CD274	0.4005277521603798	34158318
lung neoplasms/drug therapy	colitis/chemically induced	0.5483870967741937	34716545
lung neoplasms/drug therapy	colitis/chemically induced	0.5483870967741937	33173388
neoplasms/complications	PDCD1	0.1749302590817317	34158318
neoplasms/complications	PDCD1	0.1749302590817317	32960847
diarrhea/chemically induced	CHI3L1	0.15053763440860216	36096534
sarcoidosis/diagnostic imaging	colitis/diagnostic imaging	0.010752688172043012	33375984
diarrhea/chemically induced	CTLA4	0.8770712327596885	35917654
diarrhea/chemically induced	CXCL8	0.15053763440860216	36096534
diarrhea/chemically induced	IL17A	0.27980364656381485	36096534
diarrhea/chemically induced	IL6	0.27980364656381485	36096534
ht29 cells	APC	0.021505376344086023	33462141
diarrhea/chemically induced	LTF	0.15053763440860216	32584703
ht29 cells	CD274	0.16129032258064516	33462141
abdominal pain/chemically induced	antineoplastic agents immunological/therapeutic use	0.03225806451612904	36377339
diarrhea/chemically induced	PDCD1	0.7915288042266029	35917654
diarrhea/chemically induced	PDCD1	0.7915288042266029	33173388
diarrhea/chemically induced	PDCD1	0.7915288042266029	34158318
ht29 cells	CD8A	0.05376344086021506	33462141
diarrhea/chemically induced	SNCA	0.3906030855539973	32641348
diarrhea/chemically induced	TNF	0.3906030855539973	32641348
ht29 cells	IL17A	0.021505376344086023	33462141
immunologic factors	colitis/chemically induced	0.935483870967742	33566405
ht29 cells	MIR15B	0.010752688172043012	33462141
abdominal pain/chemically induced	gastritis/complications	0.010752688172043012	36377339
ht29 cells	NRF1	0.010752688172043012	33462141
abdominal pain/chemically induced	enterocolitis/chemically induced	0.021505376344086023	36377339
ht29 cells	PDCD1	0.2688172043010753	33462141
colitis/diagnostic imaging	pneumonia/diagnostic imaging	0.010752688172043012	33375984
anti-bacterial agents	colitis/chemically induced	0.7419354838709677	36043345
sarcoidosis/diagnostic imaging	pneumonia/diagnostic imaging	0.010752688172043012	33375984
hypophysitis/chemically induced	angiogenesis inhibitors/therapeutic use	0.010752688172043012	32130969
hypophysitis/chemically induced	myocarditis/chemically induced	0.010752688172043012	32130969
hypophysitis/chemically induced	hepatitis autoimmune/etiology	0.010752688172043012	32130969
hypophysitis/chemically induced	myasthenia gravis/chemically induced	0.010752688172043012	32130969
hypophysitis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
squamous cell carcinoma of head and neck/drug therapy	tongue neoplasms/drug therapy	0.010752688172043012	33476895
t-lymphocytes regulatory/cytology	CTLA4	0.12903225806451613	32603654
hypophysitis/chemically induced	ipilimumab/therapeutic use	0.03225806451612904	32130969
dermatitis	rna	0.010752688172043012	35977003
dermatitis	CTLA4	0.12903225806451613	35977003
dermatitis	CXCL10	0.010752688172043012	35977003
dermatitis	CXCL9	0.010752688172043012	35977003
t-lymphocytes regulatory/cytology	PDCD1	0.2688172043010753	32603654
dermatitis	PDCD1	0.2688172043010753	35977003
dermatitis	TCIM	0.010752688172043012	35977003
dermatitis	TNF	0.03225806451612904	35977003
colorectal neoplasms/drug therapy	b7-h1 antigen/genetics	0.010752688172043012	33462141
proton pump inhibitors/adverse effects	colitis/chemically induced	0.7419354838709677	35277350
colonic neoplasms/drug therapy	cell line tumor	0.021505376344086023	33495297
colonic neoplasms/drug therapy	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010752688172043012	33495297
crohn disease/immunology	graft vs host disease/immunology	0.010752688172043012	34338882
crohn disease/immunology	cd8-positive t-lymphocytes/drug effects	0.021505376344086023	34338882
crohn disease/immunology	phenotype	0.021505376344086023	34338882
colorectal neoplasms/drug therapy	APC	0.021505376344086023	33462141
colorectal neoplasms/drug therapy	CD274	0.16129032258064516	33462141
drug-related side effects and adverse reactions/diagnosis	CTLA4	0.12903225806451613	35191192
colonic neoplasms/drug therapy	piperazines/administration & dosage	0.010752688172043012	33495297
colorectal neoplasms/drug therapy	CD8A	0.05376344086021506	33462141
crohn disease/immunology	CD4	0.021505376344086023	34338882
crohn disease/immunology	CD68	0.021505376344086023	34338882
colonic neoplasms/drug therapy	APC	0.021505376344086023	33495297
colorectal neoplasms/drug therapy	IL17A	0.021505376344086023	33462141
crohn disease/immunology	CD8A	0.05376344086021506	34338882
colonic neoplasms/drug therapy	ARG1	0.010752688172043012	33495297
colorectal neoplasms/drug therapy	MIR15B	0.010752688172043012	33462141
colorectal neoplasms/drug therapy	NRF1	0.010752688172043012	33462141
colorectal neoplasms/drug therapy	PDCD1	0.2688172043010753	33462141
drug-related side effects and adverse reactions/diagnosis	PDCD1	0.2688172043010753	35191192
proton pump inhibitors/adverse effects	ipilimumab/therapeutic use	0.03225806451612904	35277350
colonic neoplasms/drug therapy	PARP1	0.010752688172043012	33495297
colonic neoplasms/drug therapy	PDCD1	0.2688172043010753	33495297
interleukin-23/antagonists & inhibitors	interleukin-12/antagonists & inhibitors	0.010752688172043012	33567198
colonic neoplasms/drug therapy	TIPARP	0.010752688172043012	33495297
glucocorticoids/pharmacology	melanoma/drug therapy	0.05376344086021506	32414860
inflammatory bowel diseases	gastrointestinal tract/metabolism	0.021505376344086023	32298485
glucocorticoids/pharmacology	immunosuppressive agents/pharmacology	0.010752688172043012	32414860
intestinal mucosa/immunology	colon/immunology	0.021505376344086023	33459466
glucocorticoids/pharmacology	mucositis/chemically induced	0.010752688172043012	32414860
inflammatory bowel diseases	b7-h1 antigen/metabolism	0.021505376344086023	32298485
inflammatory bowel diseases	CD274	0.2980364656381486	32298485
pericarditis/diagnostic imaging	encephalitis/diagnostic imaging	0.010752688172043012	33375984
inflammatory bowel diseases	PDCD1	0.4675081813931744	32298485
pericarditis/diagnostic imaging	colitis/diagnostic imaging	0.010752688172043012	33375984
dextran sulfate/adverse effects	colonic neoplasms/drug therapy	0.010752688172043012	33495297
dextran sulfate/adverse effects	cell line tumor	0.021505376344086023	33495297
dextran sulfate/adverse effects	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.010752688172043012	33495297
dextran sulfate/adverse effects	piperazines/administration & dosage	0.010752688172043012	33495297
oropharyngeal neoplasms/drug therapy	PDCD1	0.2688172043010753	33906378
dextran sulfate/adverse effects	APC	0.021505376344086023	33495297
dextran sulfate/adverse effects	ARG1	0.010752688172043012	33495297
immunocompromised host	prednisone/therapeutic use	0.010752688172043012	34956219
disease susceptibility	postoperative complications	0.010752688172043012	32028372
pericarditis/diagnostic imaging	pneumonia/diagnostic imaging	0.010752688172043012	33375984
vitamin d/administration & dosage	neutrophils/drug effects	0.010752688172043012	32567084
dextran sulfate/adverse effects	PARP1	0.010752688172043012	33495297
vitamin d/administration & dosage	antibodies monoclonal/adverse effects	0.010752688172043012	32567084
dextran sulfate/adverse effects	PDCD1	0.2688172043010753	33495297
dextran sulfate/adverse effects	TIPARP	0.010752688172043012	33495297
vitamin d/administration & dosage	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	32567084
vitamin d/administration & dosage	melanoma/complications	0.03225806451612904	32567084
vitamin d/administration & dosage	ctla-4 antigen/antagonists & inhibitors	0.03225806451612904	32567084
vitamin d/administration & dosage	antineoplastic agents immunological/adverse effects	0.07526881720430108	32567084
colitis/chemically induced	phthalazines/administration & dosage	0.7419354838709677	33495297
colitis/chemically induced	neoplasms/complications	0.9844026940801134	34158318
colon/immunology	t-lymphocyte subsets/immunology	0.021505376344086023	34777387
colitis/chemically induced	abdominal pain/chemically induced	0.7419354838709677	36377339
colitis/chemically induced	hypophysitis/chemically induced	0.7419354838709677	32130969
vitamin d/administration & dosage	CTLA4	0.12903225806451613	32567084
colitis/chemically induced	glucocorticoids/pharmacology	0.7419354838709677	32414860
colitis/chemically induced	dextran sulfate/adverse effects	0.7419354838709677	33495297
cytomegalovirus infections/diagnosis	antineoplastic agents immunological/adverse effects	0.07526881720430108	32434876
colitis/chemically induced	cytomegalovirus infections/diagnosis	0.7419354838709677	32434876
colitis/chemically induced	endometrial neoplasms/drug therapy	0.7419354838709677	35801666
colitis/chemically induced	angiogenesis inhibitors/therapeutic use	0.7419354838709677	32130969
ipilimumab/adverse effects	colitis/chemically induced	0.0589207356081562	34159488
ipilimumab/adverse effects	colitis/chemically induced	0.0589207356081562	33096100
ipilimumab/adverse effects	colitis/chemically induced	0.0589207356081562	33882697
ipilimumab/adverse effects	colitis/chemically induced	0.0589207356081562	34332139
ipilimumab/adverse effects	colitis/chemically induced	0.0589207356081562	31595568
ipilimumab/adverse effects	colitis/chemically induced	0.0589207356081562	32931028
ipilimumab/adverse effects	colitis/chemically induced	0.0589207356081562	35917654
ipilimumab/adverse effects	colitis/chemically induced	0.0589207356081562	35191192
ipilimumab/adverse effects	colitis/chemically induced	0.0589207356081562	32934876
colitis/chemically induced	biomarkers/metabolism	0.7419354838709677	32389505
vitamin d/administration & dosage	PDCD1	0.2688172043010753	32567084
colitis/chemically induced	dermatitis	0.7419354838709677	35977003
colitis/chemically induced	colorectal neoplasms/drug therapy	0.7419354838709677	33462141
colitis/chemically induced	anti-bacterial agents/adverse effects	0.7419354838709677	34107499
colitis/chemically induced	oropharyngeal neoplasms/drug therapy	0.7419354838709677	33906378
colitis/chemically induced	vitamin d/administration & dosage	0.7419354838709677	32567084
colitis/chemically induced	carcinoma non-small-cell lung/complications	0.7419354838709677	32418993
colitis/chemically induced	melanoma/immunology	0.7419354838709677	34956219
phosphatidylinositol 3-kinases/metabolism	antineoplastic agents immunological/therapeutic use	0.03225806451612904	34987517
colitis/chemically induced	b7-h1 antigen/genetics	0.7419354838709677	33462141
colitis/chemically induced	myocarditis/chemically induced	0.7419354838709677	32130969
colitis/chemically induced	antibodies monoclonal humanized	0.7419354838709677	35801666
phosphatidylinositol 3-kinases/metabolism	lymphocytes tumor-infiltrating/immunology	0.010752688172043012	34987517
colitis/chemically induced	colonic neoplasms/drug therapy	0.7419354838709677	33495297
colitis/chemically induced	intestinal mucosa/immunology	0.7419354838709677	33459466
carcinoma non-small-cell lung/complications	drug-related side effects and adverse reactions	0.021505376344086023	32418993
carcinoma non-small-cell lung/complications	melanoma/complications	0.03225806451612904	32418993
colitis/chemically induced	melanoma/drug therapy	0.21624467111962578	32641348
colitis/chemically induced	melanoma/drug therapy	0.21624467111962578	32162824
colitis/chemically induced	melanoma/drug therapy	0.21624467111962578	33882697
colitis/chemically induced	melanoma/drug therapy	0.21624467111962578	36338892
colitis/chemically induced	melanoma/drug therapy	0.21624467111962578	32414860
phosphatidylinositol 3-kinases/metabolism	colitis/etiology	0.021505376344086023	34987517
colitis/chemically induced	antineoplastic agents immunological/therapeutic use	0.837646224742999	36159840
colitis/chemically induced	antineoplastic agents immunological/therapeutic use	0.837646224742999	36377339
ipilimumab/adverse effects	melanoma/drug therapy	0.4059793367040795	33882697
carcinoma non-small-cell lung/complications	infliximab/administration & dosage	0.010752688172043012	32418993
phosphatidylinositol 3-kinases/metabolism	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	34987517
colitis/chemically induced	immune checkpoint inhibitors/pharmacology	0.9485288904643744	33506015
colitis/chemically induced	immune checkpoint inhibitors/pharmacology	0.9485288904643744	35236743
colitis/chemically induced	hepatitis autoimmune/etiology	0.7419354838709677	32130969
phosphatidylinositol 3-kinases/metabolism	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	34987517
paclitaxel/therapeutic use	colitis ulcerative/chemically induced	0.010752688172043012	33476895
colitis/chemically induced	piperidines/therapeutic use	0.935483870967742	33096100
ipilimumab/adverse effects	piperidines/therapeutic use	0.18513323983169702	33096100
colitis/chemically induced	adrenal cortex hormones/pharmacology	0.7419354838709677	33268234
ipilimumab/adverse effects	drug-related side effects and adverse reactions/diagnosis	0.09677419354838711	35191192
colitis/chemically induced	drug-related side effects and adverse reactions/diagnosis	0.7419354838709677	35191192
phosphatidylinositol 3-kinases/metabolism	cell line tumor	0.021505376344086023	34987517
colitis/chemically induced	immunocompromised host	0.7419354838709677	34956219
colitis/chemically induced	colon/immunology	0.5483870967741936	33459466
colitis/chemically induced	colon/immunology	0.5483870967741936	34777387
colitis/chemically induced	dose-response relationship drug	0.5483870967741936	33290513
colitis/chemically induced	dose-response relationship drug	0.5483870967741936	32540858
colitis/chemically induced	neutrophils/drug effects	0.7419354838709677	32567084
colitis/chemically induced	myasthenia gravis/chemically induced	0.7419354838709677	32130969
colitis/chemically induced	antibodies monoclonal/adverse effects	0.7419354838709677	32567084
paclitaxel/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	33476895
colitis/chemically induced	immunosuppressive agents/pharmacology	0.7419354838709677	32414860
colitis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.935483870967742	32130969
carcinoma non-small-cell lung/complications	ACAD8	0.021505376344086023	32418993
colitis/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.9747908768090005	32540858
colitis/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.9747908768090005	32567084
colitis/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.9747908768090005	32702598
colitis/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.9747908768090005	33506015
phosphatidylinositol 3-kinases/metabolism	cd8-positive t-lymphocytes/immunology	0.010752688172043012	34987517
dose-response relationship drug	programmed cell death 1 receptor/antagonists & inhibitors	0.16549789621318373	32540858
colitis/chemically induced	drug-related side effects and adverse reactions	0.5483870967741936	32162824
colitis/chemically induced	drug-related side effects and adverse reactions	0.5483870967741936	32418993
colitis/chemically induced	gastrointestinal neoplasms/drug therapy	0.7419354838709677	36159840
carcinoma non-small-cell lung/complications	CRP	0.010752688172043012	32418993
colitis/chemically induced	melanoma/complications	0.837646224742999	32418993
colitis/chemically induced	melanoma/complications	0.837646224742999	32567084
colitis/chemically induced	cell line tumor	0.935483870967742	33495297
paclitaxel/therapeutic use	antineoplastic agents immunological/adverse effects	0.07526881720430108	33476895
colitis/chemically induced	adenocarcinoma of lung/drug therapy	0.7419354838709677	32389505
colitis/chemically induced	trinitrobenzenesulfonic acid/adverse effects	0.7419354838709677	33506015
colitis/chemically induced	ctla-4 antigen/antagonists & inhibitors	0.837646224742999	32567084
colitis/chemically induced	ctla-4 antigen/antagonists & inhibitors	0.837646224742999	32702598
colitis/chemically induced	t-lymphocyte subsets/immunology	0.7419354838709677	34777387
colitis/chemically induced	mucositis/chemically induced	0.7419354838709677	32414860
colitis/chemically induced	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.7419354838709677	33495297
phosphatidylinositol 3-kinases/metabolism	cytotoxicity immunologic	0.010752688172043012	34987517
colitis/chemically induced	gastritis/complications	0.7419354838709677	36377339
colitis/chemically induced	infliximab/administration & dosage	0.7419354838709677	32418993
colitis/chemically induced	biological products/therapeutic use	0.7419354838709677	34380976
colitis/chemically induced	enterocolitis/chemically induced	0.935483870967742	36377339
colitis/chemically induced	lung neoplasms	0.7419354838709677	31864555
melanoma/immunology	immunocompromised host	0.010752688172043012	34956219
colitis/chemically induced	cd8-positive t-lymphocytes	0.7419354838709677	34106395
dose-response relationship drug	drugs investigational/administration & dosage	0.021505376344086023	32540858
phosphatidylinositol 3-kinases/metabolism	CD8A	0.05376344086021506	34987517
colitis/chemically induced	beclomethasone/adverse effects	0.7419354838709677	36113896
colitis/chemically induced	hepatitis/diagnosis	0.7419354838709677	32185493
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7449933967412815	32422528
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7449933967412815	32702598
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7449933967412815	32567084
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7449933967412815	36338892
colitis/chemically induced	antineoplastic agents immunological/adverse effects	0.7449933967412815	32434876
paclitaxel/therapeutic use	SNCA	0.03225806451612904	33476895
colitis/chemically induced	ipilimumab/therapeutic use	0.4037575327897908	35124713
colitis/chemically induced	ipilimumab/therapeutic use	0.4037575327897908	32130969
colitis/chemically induced	ipilimumab/therapeutic use	0.4037575327897908	35277350
dose-response relationship drug	steroids/therapeutic use	0.04277699859747545	33290513
ipilimumab/adverse effects	CD274	0.44474115731587344	32934876
ipilimumab/adverse effects	CD274	0.44474115731587344	35917654
colitis/chemically induced	drugs investigational/administration & dosage	0.7419354838709677	32540858
colitis/chemically induced	cytomegalovirus infections/complications	0.7419354838709677	35307927
colitis/chemically induced	butyrates/metabolism	0.7419354838709677	33741313
endometrial neoplasms/drug therapy	antibodies monoclonal humanized	0.010752688172043012	35801666
dose-response relationship drug	CD274	0.2980364656381486	32540858
phosphatidylinositol 3-kinases/metabolism	MTOR	0.010752688172043012	34987517
colitis/chemically induced	inflammatory bowel diseases/complications	0.935483870967742	34158318
colitis/chemically induced	rna	0.7419354838709677	35977003
phosphatidylinositol 3-kinases/metabolism	PDCD1	0.2688172043010753	34987517
colitis/chemically induced	steroids/therapeutic use	0.5483870967741936	33290513
colitis/chemically induced	steroids/therapeutic use	0.5483870967741936	31864555
colitis/chemically induced	piperazines/administration & dosage	0.7419354838709677	33495297
melanoma/complications	ctla-4 antigen/antagonists & inhibitors	0.09467811291093199	32567084
colitis/chemically induced	inflammation	0.7419354838709677	32888202
melanoma/immunology	prednisone/therapeutic use	0.010752688172043012	34956219
colitis/chemically induced	prednisone/therapeutic use	0.7419354838709677	34956219
colitis/chemically induced	ACAD8	0.5483870967741936	32418993
colitis/chemically induced	ACAD8	0.5483870967741936	33506015
melanoma/complications	infliximab/administration & dosage	0.03225806451612903	32418993
colitis/chemically induced	AHR	0.7419354838709677	35236743
colitis/chemically induced	APC	0.5483870967741936	33495297
colitis/chemically induced	APC	0.5483870967741936	33462141
colitis/chemically induced	ARG1	0.7419354838709677	33495297
colitis/chemically induced	BTLA	0.7419354838709677	36159840
colitis/chemically induced	CD274	0.6678116065345758	36159840
colitis/chemically induced	CD274	0.6678116065345758	32389505
colitis/chemically induced	CD274	0.6678116065345758	34992611
colitis/chemically induced	CD274	0.6678116065345758	32702598
colitis/chemically induced	CD274	0.6678116065345758	33555016
colitis/chemically induced	CD274	0.6678116065345758	33173388
colitis/chemically induced	CD274	0.6678116065345758	34158318
colitis/chemically induced	CD274	0.6678116065345758	35917654
colitis/chemically induced	CD274	0.6678116065345758	32540858
colitis/chemically induced	CD274	0.6678116065345758	32934876
colitis/chemically induced	CD274	0.6678116065345758	33462141
colitis/chemically induced	CD28	0.7419354838709677	36159840
melanoma/complications	antineoplastic agents immunological/adverse effects	0.2113496601575143	32567084
colitis/chemically induced	CD4	0.935483870967742	33555016
dose-response relationship drug	PDCD1	0.4675081813931744	32540858
colitis/chemically induced	CD68	0.935483870967742	33555016
colitis/chemically induced	CD8A	0.9850744881553145	33555016
colitis/chemically induced	CD8A	0.9850744881553145	33462141
colitis ulcerative/chemically induced	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	33476895
colitis/chemically induced	CHI3L1	0.7419354838709677	36096534
colitis/chemically induced	CRP	0.7419354838709677	32418993
neutrophils/drug effects	antibodies monoclonal/adverse effects	0.010752688172043012	32567084
colitis/chemically induced	CSF2	0.7419354838709677	36159840
colitis/chemically induced	CTLA4	0.8401476476282531	34992611
colitis/chemically induced	CTLA4	0.8401476476282531	32702598
colitis/chemically induced	CTLA4	0.8401476476282531	33555016
colitis/chemically induced	CTLA4	0.8401476476282531	35977003
colitis/chemically induced	CTLA4	0.8401476476282531	32567084
colitis/chemically induced	CTLA4	0.8401476476282531	35917654
colitis/chemically induced	CTLA4	0.8401476476282531	35191192
colitis/chemically induced	CTLA4	0.8401476476282531	32934876
colitis/chemically induced	CXCL10	0.7419354838709677	35977003
neutrophils/drug effects	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	32567084
colitis/chemically induced	CXCL8	0.7419354838709677	36096534
colitis/chemically induced	CXCL9	0.7419354838709677	35977003
colitis/chemically induced	HAVCR2	0.7419354838709677	36159840
melanoma/complications	ACAD8	0.0638148667601683	32418993
colitis/chemically induced	IL15	0.7419354838709677	36159840
neutrophils/drug effects	melanoma/complications	0.03225806451612904	32567084
colitis/chemically induced	IL17A	0.5483870967741936	33462141
colitis/chemically induced	IL17A	0.5483870967741936	36096534
colitis/chemically induced	IL17C	0.7419354838709677	36159840
colitis/chemically induced	IL21	0.7419354838709677	36159840
neutrophils/drug effects	ctla-4 antigen/antagonists & inhibitors	0.03225806451612904	32567084
colitis/chemically induced	IL22	0.5483870967741936	36159840
colitis/chemically induced	IL22	0.5483870967741936	35236743
colitis/chemically induced	IL4	0.7419354838709677	36159840
colitis/chemically induced	IL6	0.5483870967741936	36159840
colitis/chemically induced	IL6	0.5483870967741936	36096534
melanoma/complications	CRP	0.03225806451612903	32418993
colitis/chemically induced	LIF	0.7419354838709677	36159840
colitis ulcerative/chemically induced	antineoplastic agents immunological/adverse effects	0.07526881720430108	33476895
colitis/chemically induced	LTF	0.7419354838709677	32584703
melanoma/complications	CTLA4	0.3425088235747422	32567084
colitis/chemically induced	MIR15B	0.7419354838709677	33462141
colitis/chemically induced	NRF1	0.7419354838709677	33462141
colitis/chemically induced	PARP1	0.7419354838709677	33495297
endometrial neoplasms/drug therapy	PDCD1	0.2688172043010753	35801666
colitis/chemically induced	PDCD1	0.9458513386676314	36159840
colitis/chemically induced	PDCD1	0.9458513386676314	33495297
colitis/chemically induced	PDCD1	0.9458513386676314	35801666
colitis/chemically induced	PDCD1	0.9458513386676314	34992611
colitis/chemically induced	PDCD1	0.9458513386676314	32702598
colitis/chemically induced	PDCD1	0.9458513386676314	33555016
colitis/chemically induced	PDCD1	0.9458513386676314	33906378
colitis/chemically induced	PDCD1	0.9458513386676314	35977003
colitis/chemically induced	PDCD1	0.9458513386676314	33173388
colitis/chemically induced	PDCD1	0.9458513386676314	32567084
colitis/chemically induced	PDCD1	0.9458513386676314	34158318
colitis/chemically induced	PDCD1	0.9458513386676314	35917654
colitis/chemically induced	PDCD1	0.9458513386676314	35191192
colitis/chemically induced	PDCD1	0.9458513386676314	32540858
colitis/chemically induced	PDCD1	0.9458513386676314	33462141
colitis/chemically induced	PDCD1	0.9458513386676314	33506015
neutrophils/drug effects	antineoplastic agents immunological/adverse effects	0.07526881720430108	32567084
colitis/chemically induced	SNCA	0.837646224742999	32934876
colitis/chemically induced	SNCA	0.837646224742999	32641348
colitis/chemically induced	TCIM	0.7419354838709677	35977003
colitis/chemically induced	TIPARP	0.7419354838709677	33495297
colitis/chemically induced	TNF	0.4037575327897908	32162824
colitis/chemically induced	TNF	0.4037575327897908	35977003
colitis/chemically induced	TNF	0.4037575327897908	32641348
receptors antigen t-cell/genetics	t-lymphocytes regulatory/cytology	0.010752688172043012	32603654
melanoma/complications	PDCD1	0.1749302590817317	32567084
melanoma/complications	PDCD1	0.1749302590817317	32404733
phthalazines/administration & dosage	dextran sulfate/adverse effects	0.010752688172043012	33495297
b7-h1 antigen/genetics	APC	0.021505376344086023	33462141
b7-h1 antigen/genetics	CD274	0.16129032258064516	33462141
b7-h1 antigen/genetics	CD8A	0.05376344086021506	33462141
cell line tumor	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.021505376344086023	33495297
b7-h1 antigen/genetics	IL17A	0.021505376344086023	33462141
cell line tumor	cd8-positive t-lymphocytes/immunology	0.021505376344086023	34987517
phthalazines/administration & dosage	colonic neoplasms/drug therapy	0.010752688172043012	33495297
neutrophils/drug effects	CTLA4	0.12903225806451613	32567084
receptors antigen t-cell/genetics	chemokines/metabolism	0.010752688172043012	32603654
receptors antigen t-cell/genetics	multigene family	0.010752688172043012	32603654
b7-h1 antigen/genetics	MIR15B	0.010752688172043012	33462141
colitis ulcerative/chemically induced	SNCA	0.03225806451612904	33476895
b7-h1 antigen/genetics	NRF1	0.010752688172043012	33462141
b7-h1 antigen/genetics	PDCD1	0.2688172043010753	33462141
cell line tumor	piperazines/administration & dosage	0.021505376344086023	33495297
neutrophils/drug effects	PDCD1	0.2688172043010753	32567084
cell line tumor	cytotoxicity immunologic	0.021505376344086023	34987517
myocarditis/chemically induced	hepatitis autoimmune/etiology	0.010752688172043012	32130969
cell line tumor	APC	0.04277699859747545	33495297
cell line tumor	ARG1	0.021505376344086023	33495297
myasthenia gravis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
myocarditis/chemically induced	myasthenia gravis/chemically induced	0.010752688172043012	32130969
myocarditis/chemically induced	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
feces/chemistry	leukocyte l1 antigen complex/analysis	0.010752688172043012	33436487
receptors antigen t-cell/genetics	CTLA4	0.12903225806451613	32603654
cell line tumor	CD8A	0.10518934081346423	34987517
receptors antigen t-cell/genetics	PDCD1	0.2688172043010753	32603654
myocarditis/chemically induced	ipilimumab/therapeutic use	0.03225806451612904	32130969
cell line tumor	MTOR	0.021505376344086023	34987517
angiogenesis inhibitors/therapeutic use	myocarditis/chemically induced	0.010752688172043012	32130969
cell line tumor	PARP1	0.021505376344086023	33495297
cell line tumor	PDCD1	0.07012622720897614	33495297
cell line tumor	PDCD1	0.07012622720897614	34987517
myasthenia gravis/chemically induced	ipilimumab/therapeutic use	0.03225806451612904	32130969
cell line tumor	TIPARP	0.021505376344086023	33495297
feces/chemistry	biomarkers/analysis	0.010752688172043012	33436487
angiogenesis inhibitors/therapeutic use	hepatitis autoimmune/etiology	0.010752688172043012	32130969
angiogenesis inhibitors/therapeutic use	myasthenia gravis/chemically induced	0.010752688172043012	32130969
angiogenesis inhibitors/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
angiogenesis inhibitors/therapeutic use	ipilimumab/therapeutic use	0.03225806451612904	32130969
adenocarcinoma of lung/drug therapy	CD274	0.16129032258064516	32389505
antibodies monoclonal/adverse effects	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	32567084
antibodies monoclonal/adverse effects	melanoma/complications	0.03225806451612904	32567084
antibodies monoclonal/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.03225806451612904	32567084
melanoma/drug therapy	immunosuppressive agents/pharmacology	0.05376344086021506	32414860
melanoma/drug therapy	drug-related side effects and adverse reactions	0.10518934081346423	32162824
antibodies monoclonal/adverse effects	antineoplastic agents immunological/adverse effects	0.07526881720430108	32567084
melanoma/drug therapy	mucositis/chemically induced	0.05376344086021506	32414860
antibodies monoclonal humanized	PDCD1	0.2688172043010753	35801666
melanoma/drug therapy	antineoplastic agents immunological/adverse effects	0.32989335668315134	36338892
cd8-positive t-lymphocytes/drug effects	phenotype	0.00023375409069658717	34338882
cd8-positive t-lymphocytes/drug effects	phenotype	0.00023375409069658717	34147519
trinitrobenzenesulfonic acid/adverse effects	ACAD8	0.021505376344086023	33506015
antibodies monoclonal/adverse effects	CTLA4	0.12903225806451613	32567084
t-lymphocytes regulatory/cytology	chemokines/metabolism	0.010752688172043012	32603654
t-lymphocytes regulatory/cytology	multigene family	0.010752688172043012	32603654
cd8-positive t-lymphocytes/drug effects	CD4	0.04277699859747545	34338882
cd8-positive t-lymphocytes/drug effects	CD68	0.04277699859747545	34338882
cd8-positive t-lymphocytes/drug effects	CD8A	0.0023375409069658717	34338882
cd8-positive t-lymphocytes/drug effects	CD8A	0.0023375409069658717	34147519
cd8-positive t-lymphocytes/drug effects	CTLA4	0.24263674614305747	34147519
antibodies monoclonal/adverse effects	PDCD1	0.2688172043010753	32567084
trinitrobenzenesulfonic acid/adverse effects	PDCD1	0.2688172043010753	33506015
colitis/etiology	immune checkpoint inhibitors/therapeutic use	0.04277699859747545	34987517
colitis/etiology	programmed cell death 1 receptor/antagonists & inhibitors	0.16549789621318373	34987517
chemokines/metabolism	multigene family	0.010752688172043012	32603654
melanoma/drug therapy	SNCA	0.15435476164788925	32641348
colitis/etiology	cell line tumor	0.04277699859747545	34987517
cd8-positive t-lymphocytes/drug effects	PDCD1	0.4675081813931744	34147519
melanoma/drug therapy	TNF	0.006858499144614151	32162824
melanoma/drug therapy	TNF	0.006858499144614151	32641348
antineoplastic agents immunological/therapeutic use	lymphocytes tumor-infiltrating/immunology	0.03225806451612903	34987517
colitis/etiology	cd8-positive t-lymphocytes/immunology	0.021505376344086023	34987517
antineoplastic agents immunological/therapeutic use	colitis/etiology	0.0638148667601683	34987517
colitis/etiology	antineoplastic agents immunological/adverse effects	0.14562879850397378	34162429
antineoplastic agents immunological/therapeutic use	immune checkpoint inhibitors/therapeutic use	0.0638148667601683	34987517
drugs investigational/administration & dosage	CD274	0.16129032258064516	32540858
antineoplastic agents immunological/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.23886071852411256	34987517
antineoplastic agents immunological/therapeutic use	gastrointestinal neoplasms/drug therapy	0.03225806451612903	36159840
antineoplastic agents immunological/therapeutic use	cell line tumor	0.0638148667601683	34987517
colitis/etiology	anti-bacterial agents/pharmacology	0.021505376344086023	34162429
colitis/etiology	cytotoxicity immunologic	0.021505376344086023	34987517
chemokines/metabolism	CTLA4	0.12903225806451613	32603654
antineoplastic agents immunological/therapeutic use	gastritis/complications	0.03225806451612903	36377339
antineoplastic agents immunological/therapeutic use	enterocolitis/chemically induced	0.0638148667601683	36377339
drugs investigational/administration & dosage	PDCD1	0.2688172043010753	32540858
colitis/etiology	CD8A	0.10518934081346423	34987517
antineoplastic agents immunological/therapeutic use	cd8-positive t-lymphocytes/immunology	0.03225806451612903	34987517
chemokines/metabolism	PDCD1	0.2688172043010753	32603654
colitis/etiology	MTOR	0.021505376344086023	34987517
antineoplastic agents immunological/therapeutic use	cytotoxicity immunologic	0.03225806451612903	34987517
colitis/etiology	PDCD1	0.4675081813931744	34987517
antineoplastic agents immunological/therapeutic use	BTLA	0.03225806451612903	36159840
ctla-4 antigen/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.01418707519689287	32567084
ctla-4 antigen/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.01418707519689287	32702598
antineoplastic agents immunological/therapeutic use	CD274	0.41374474053295934	36159840
antineoplastic agents immunological/therapeutic use	CD28	0.03225806451612903	36159840
ctla-4 antigen/antagonists & inhibitors	cd8-positive t-lymphocytes/drug effects	0.0638148667601683	34147519
antineoplastic agents immunological/therapeutic use	CD8A	0.15435476164788925	34987517
antineoplastic agents immunological/therapeutic use	CSF2	0.03225806451612903	36159840
ctla-4 antigen/antagonists & inhibitors	phenotype	0.0638148667601683	34147519
immunosuppressive agents/pharmacology	mucositis/chemically induced	0.010752688172043012	32414860
antineoplastic agents immunological/therapeutic use	HAVCR2	0.03225806451612903	36159840
antineoplastic agents immunological/therapeutic use	IL15	0.03225806451612903	36159840
antineoplastic agents immunological/therapeutic use	IL17C	0.03225806451612903	36159840
antineoplastic agents immunological/therapeutic use	IL21	0.03225806451612903	36159840
antineoplastic agents immunological/therapeutic use	IL22	0.0638148667601683	36159840
antineoplastic agents immunological/therapeutic use	IL4	0.03225806451612903	36159840
ctla-4 antigen/antagonists & inhibitors	CD274	0.41374474053295934	32702598
antineoplastic agents immunological/therapeutic use	IL6	0.0638148667601683	36159840
antineoplastic agents immunological/therapeutic use	LIF	0.03225806451612903	36159840
ctla-4 antigen/antagonists & inhibitors	CD8A	0.15435476164788925	34147519
antineoplastic agents immunological/therapeutic use	MTOR	0.03225806451612903	34987517
antineoplastic agents immunological/therapeutic use	PDCD1	0.1749302590817317	36159840
antineoplastic agents immunological/therapeutic use	PDCD1	0.1749302590817317	34987517
ctla-4 antigen/antagonists & inhibitors	CTLA4	0.0016953593391181047	32567084
ctla-4 antigen/antagonists & inhibitors	CTLA4	0.0016953593391181047	32702598
ctla-4 antigen/antagonists & inhibitors	CTLA4	0.0016953593391181047	34147519
ctla-4 antigen/antagonists & inhibitors	PDCD1	0.017724211272598368	32567084
ctla-4 antigen/antagonists & inhibitors	PDCD1	0.017724211272598368	32702598
ctla-4 antigen/antagonists & inhibitors	PDCD1	0.017724211272598368	34147519
immune checkpoint inhibitors/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.16549789621318373	34987517
phenotype	CD4	0.04277699859747545	34338882
phenotype	CD68	0.04277699859747545	34338882
phenotype	CD8A	0.0023375409069658717	34338882
phenotype	CD8A	0.0023375409069658717	34147519
immune checkpoint inhibitors/therapeutic use	cell line tumor	0.04277699859747545	34987517
phenotype	CTLA4	0.24263674614305747	34147519
immune checkpoint inhibitors/therapeutic use	cd8-positive t-lymphocytes/immunology	0.021505376344086023	34987517
phenotype	PDCD1	0.4675081813931744	34147519
immune checkpoint inhibitors/therapeutic use	ipilimumab/therapeutic use	0.0638148667601683	32130969
immune checkpoint inhibitors/therapeutic use	cytotoxicity immunologic	0.021505376344086023	34987517
immune checkpoint inhibitors/therapeutic use	CD8A	0.10518934081346423	34987517
immune checkpoint inhibitors/pharmacology	inflammatory bowel diseases	0.08461898083216456	32298485
immune checkpoint inhibitors/pharmacology	programmed cell death 1 receptor/antagonists & inhibitors	0.30651754354419153	33506015
immune checkpoint inhibitors/pharmacology	melanoma/complications	0.12485550914723427	32404733
immune checkpoint inhibitors/therapeutic use	MTOR	0.021505376344086023	34987517
immune checkpoint inhibitors/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0.04301075268817204	33506015
immune checkpoint inhibitors/therapeutic use	PDCD1	0.4675081813931744	34987517
b7-h1 antigen/metabolism	CD274	0.16129032258064516	32298485
immune checkpoint inhibitors/pharmacology	gastrointestinal tract/metabolism	0.04301075268817204	32298485
immune checkpoint inhibitors/pharmacology	b7-h1 antigen/metabolism	0.04301075268817204	32298485
b7-h1 antigen/metabolism	PDCD1	0.2688172043010753	32298485
immune checkpoint inhibitors/pharmacology	ACAD8	0.08461898083216456	33506015
leukocyte l1 antigen complex/analysis	biomarkers/analysis	0.010752688172043012	33436487
immune checkpoint inhibitors/pharmacology	AHR	0.04301075268817204	35236743
immune checkpoint inhibitors/pharmacology	CD274	0.5114539504441326	32298485
inflammatory bowel diseases/complications	CD274	0.2980364656381486	34158318
immune checkpoint inhibitors/pharmacology	IL22	0.08461898083216456	35236743
multigene family	CTLA4	0.12903225806451613	32603654
immune checkpoint inhibitors/pharmacology	PDCD1	0.05789909015715467	32298485
immune checkpoint inhibitors/pharmacology	PDCD1	0.05789909015715467	32404733
immune checkpoint inhibitors/pharmacology	PDCD1	0.05789909015715467	33506015
inflammatory bowel diseases/complications	PDCD1	0.07012622720897614	32401685
inflammatory bowel diseases/complications	PDCD1	0.07012622720897614	34158318
hepatitis autoimmune/etiology	myasthenia gravis/chemically induced	0.010752688172043012	32130969
multigene family	PDCD1	0.2688172043010753	32603654
hepatitis autoimmune/etiology	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	32130969
programmed cell death 1 receptor/antagonists & inhibitors	melanoma/complications	0.23886071852411256	32567084
programmed cell death 1 receptor/antagonists & inhibitors	cell line tumor	0.1654978962131837	34987517
programmed cell death 1 receptor/antagonists & inhibitors	trinitrobenzenesulfonic acid/adverse effects	0.08602150537634409	33506015
programmed cell death 1 receptor/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.00043154601359369935	32567084
programmed cell death 1 receptor/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.00043154601359369935	32702598
programmed cell death 1 receptor/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.00043154601359369935	34147519
programmed cell death 1 receptor/antagonists & inhibitors	cd8-positive t-lymphocytes/immunology	0.08602150537634409	34987517
programmed cell death 1 receptor/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.012719967331643009	32567084
programmed cell death 1 receptor/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.012719967331643009	32702598
programmed cell death 1 receptor/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.012719967331643009	33476895
programmed cell death 1 receptor/antagonists & inhibitors	cd8-positive t-lymphocytes/drug effects	0.1654978962131837	34147519
hepatitis autoimmune/etiology	ipilimumab/therapeutic use	0.03225806451612904	32130969
poly(adp-ribose) polymerase inhibitors/administration & dosage	piperazines/administration & dosage	0.010752688172043012	33495297
programmed cell death 1 receptor/antagonists & inhibitors	drugs investigational/administration & dosage	0.08602150537634409	32540858
programmed cell death 1 receptor/antagonists & inhibitors	phenotype	0.1654978962131837	34147519
poly(adp-ribose) polymerase inhibitors/administration & dosage	APC	0.021505376344086023	33495297
poly(adp-ribose) polymerase inhibitors/administration & dosage	ARG1	0.010752688172043012	33495297
programmed cell death 1 receptor/antagonists & inhibitors	cytotoxicity immunologic	0.08602150537634409	34987517
programmed cell death 1 receptor/antagonists & inhibitors	ACAD8	0.1654978962131837	33506015
programmed cell death 1 receptor/antagonists & inhibitors	CD274	0.11583310816838854	32540858
programmed cell death 1 receptor/antagonists & inhibitors	CD274	0.11583310816838854	32702598
programmed cell death 1 receptor/antagonists & inhibitors	CD274	0.11583310816838854	32960847
programmed cell death 1 receptor/antagonists & inhibitors	CD8A	0.057175536728619906	34987517
programmed cell death 1 receptor/antagonists & inhibitors	CD8A	0.057175536728619906	34147519
rna	CTLA4	0.12903225806451613	35977003
rna	CXCL10	0.010752688172043012	35977003
programmed cell death 1 receptor/antagonists & inhibitors	CTLA4	0.06412845483493237	32567084
programmed cell death 1 receptor/antagonists & inhibitors	CTLA4	0.06412845483493237	32702598
programmed cell death 1 receptor/antagonists & inhibitors	CTLA4	0.06412845483493237	34147519
rna	CXCL9	0.010752688172043012	35977003
poly(adp-ribose) polymerase inhibitors/administration & dosage	PARP1	0.010752688172043012	33495297
poly(adp-ribose) polymerase inhibitors/administration & dosage	PDCD1	0.2688172043010753	33495297
poly(adp-ribose) polymerase inhibitors/administration & dosage	TIPARP	0.010752688172043012	33495297
programmed cell death 1 receptor/antagonists & inhibitors	MTOR	0.08602150537634409	34987517
gastritis/complications	enterocolitis/chemically induced	0.021505376344086023	36377339
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00033158579236400516	34147519
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00033158579236400516	32702598
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00033158579236400516	32567084
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00033158579236400516	32960847
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00033158579236400516	32540858
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00033158579236400516	34987517
programmed cell death 1 receptor/antagonists & inhibitors	PDCD1	0.00033158579236400516	33506015
programmed cell death 1 receptor/antagonists & inhibitors	SNCA	0.23886071852411256	33476895
rna	PDCD1	0.2688172043010753	35977003
drug-related side effects and adverse reactions	melanoma/complications	0.0638148667601683	32418993
rna	TCIM	0.010752688172043012	35977003
rna	TNF	0.03225806451612904	35977003
drug-related side effects and adverse reactions	infliximab/administration & dosage	0.021505376344086023	32418993
piperidines/therapeutic use	programmed cell death 1 receptor/antagonists & inhibitors	0.16549789621318373	34147519
drug-related side effects and adverse reactions	ACAD8	0.04277699859747545	32418993
drug-related side effects and adverse reactions	CRP	0.021505376344086023	32418993
piperidines/therapeutic use	ctla-4 antigen/antagonists & inhibitors	0.0638148667601683	34147519
drug-related side effects and adverse reactions	TNF	0.0638148667601683	32162824
infliximab/administration & dosage	ACAD8	0.021505376344086023	32418993
piperazines/administration & dosage	APC	0.021505376344086023	33495297
piperazines/administration & dosage	ARG1	0.010752688172043012	33495297
infliximab/administration & dosage	CRP	0.010752688172043012	32418993
piperidines/therapeutic use	cd8-positive t-lymphocytes/drug effects	0.04277699859747545	34147519
piperidines/therapeutic use	phenotype	0.04277699859747545	34147519
gastrointestinal neoplasms/drug therapy	BTLA	0.010752688172043012	36159840
gastrointestinal neoplasms/drug therapy	CD274	0.16129032258064516	36159840
piperidines/therapeutic use	CD8A	0.10518934081346423	34147519
gastrointestinal neoplasms/drug therapy	CD28	0.010752688172043012	36159840
piperazines/administration & dosage	PARP1	0.010752688172043012	33495297
piperazines/administration & dosage	PDCD1	0.2688172043010753	33495297
gastrointestinal neoplasms/drug therapy	CSF2	0.010752688172043012	36159840
piperidines/therapeutic use	CTLA4	0.24263674614305747	34147519
piperazines/administration & dosage	TIPARP	0.010752688172043012	33495297
gastrointestinal neoplasms/drug therapy	HAVCR2	0.010752688172043012	36159840
gastrointestinal neoplasms/drug therapy	IL15	0.010752688172043012	36159840
gastrointestinal neoplasms/drug therapy	IL17C	0.010752688172043012	36159840
gastrointestinal neoplasms/drug therapy	IL21	0.010752688172043012	36159840
gastrointestinal neoplasms/drug therapy	IL22	0.021505376344086023	36159840
gastrointestinal neoplasms/drug therapy	IL4	0.010752688172043012	36159840
gastrointestinal neoplasms/drug therapy	IL6	0.021505376344086023	36159840
gastrointestinal neoplasms/drug therapy	LIF	0.010752688172043012	36159840
gastrointestinal neoplasms/drug therapy	PDCD1	0.2688172043010753	36159840
piperidines/therapeutic use	PDCD1	0.4675081813931744	34147519
lymphocytes tumor-infiltrating/immunology	colitis/etiology	0.021505376344086023	34987517
lymphocytes tumor-infiltrating/immunology	immune checkpoint inhibitors/therapeutic use	0.021505376344086023	34987517
lymphocytes tumor-infiltrating/immunology	programmed cell death 1 receptor/antagonists & inhibitors	0.08602150537634409	34987517
lymphocytes tumor-infiltrating/immunology	cell line tumor	0.021505376344086023	34987517
ligands	CD274	0.16129032258064516	35432346
ligands	CTLA4	0.12903225806451613	35432346
cytotoxicity immunologic	CD8A	0.05376344086021506	34987517
lymphocytes tumor-infiltrating/immunology	cd8-positive t-lymphocytes/immunology	0.010752688172043012	34987517
ligands	PDCD1	0.2688172043010753	35432346
cytotoxicity immunologic	MTOR	0.010752688172043012	34987517
cytotoxicity immunologic	PDCD1	0.2688172043010753	34987517
lung neoplasms	steroids/therapeutic use	0.021505376344086023	31864555
lymphocytes tumor-infiltrating/immunology	cytotoxicity immunologic	0.010752688172043012	34987517
lymphocytes tumor-infiltrating/immunology	CD8A	0.05376344086021506	34987517
lymphocytes tumor-infiltrating/immunology	MTOR	0.010752688172043012	34987517
lymphocytes tumor-infiltrating/immunology	PDCD1	0.2688172043010753	34987517
ACAD8	CRP	0.021505376344086023	32418993
ACAD8	PDCD1	0.4675081813931744	33506015
graft vs host disease/immunology	cd8-positive t-lymphocytes/drug effects	0.021505376344086023	34338882
graft vs host disease/immunology	phenotype	0.021505376344086023	34338882
graft vs host disease/immunology	CD4	0.021505376344086023	34338882
graft vs host disease/immunology	CD68	0.021505376344086023	34338882
graft vs host disease/immunology	CD8A	0.05376344086021506	34338882
AHR	IL22	0.021505376344086023	35236743
APC	ARG1	0.021505376344086023	33495297
APC	CD274	0.2980364656381486	33462141
APC	CD8A	0.10518934081346423	33462141
gastrointestinal tract/metabolism	b7-h1 antigen/metabolism	0.010752688172043012	32298485
APC	IL17A	0.04277699859747545	33462141
gastrointestinal tract/metabolism	CD274	0.16129032258064516	32298485
APC	MIR15B	0.021505376344086023	33462141
APC	NRF1	0.021505376344086023	33462141
APC	PARP1	0.021505376344086023	33495297
APC	PDCD1	0.07012622720897614	33495297
APC	PDCD1	0.07012622720897614	33462141
APC	TIPARP	0.021505376344086023	33495297
gastrointestinal tract/metabolism	PDCD1	0.2688172043010753	32298485
ARG1	PARP1	0.010752688172043012	33495297
ARG1	PDCD1	0.2688172043010753	33495297
ARG1	TIPARP	0.010752688172043012	33495297
BTLA	CD274	0.16129032258064516	36159840
cd8-positive t-lymphocytes/immunology	cytotoxicity immunologic	0.010752688172043012	34987517
BTLA	CD28	0.010752688172043012	36159840
BTLA	CSF2	0.010752688172043012	36159840
BTLA	HAVCR2	0.010752688172043012	36159840
cd8-positive t-lymphocytes/immunology	CD8A	0.05376344086021506	34987517
BTLA	IL15	0.010752688172043012	36159840
BTLA	IL17C	0.010752688172043012	36159840
BTLA	IL21	0.010752688172043012	36159840
BTLA	IL22	0.021505376344086023	36159840
BTLA	IL4	0.010752688172043012	36159840
BTLA	IL6	0.021505376344086023	36159840
BTLA	LIF	0.010752688172043012	36159840
cd8-positive t-lymphocytes/immunology	MTOR	0.010752688172043012	34987517
BTLA	PDCD1	0.2688172043010753	36159840
cd8-positive t-lymphocytes/immunology	PDCD1	0.2688172043010753	34987517
CD274	CD28	0.16129032258064516	36159840
CD274	CD4	0.2980364656381486	33555016
CD274	CD68	0.2980364656381486	33555016
CD274	CD8A	0.18209706310309867	33555016
CD274	CD8A	0.18209706310309867	33462141
CD274	CSF2	0.16129032258064516	36159840
CD274	CTLA4	0.00034907784548984946	34992611
CD274	CTLA4	0.00034907784548984946	32702598
CD274	CTLA4	0.00034907784548984946	33555016
CD274	CTLA4	0.00034907784548984946	35917654
CD274	CTLA4	0.00034907784548984946	35432346
CD274	CTLA4	0.00034907784548984946	32934876
CD274	CTLA4	0.00034907784548984946	33314269
CD274	HAVCR2	0.16129032258064516	36159840
CD274	IL15	0.16129032258064516	36159840
CD274	IL17A	0.2980364656381486	33462141
CD274	IL17C	0.16129032258064516	36159840
CD274	IL21	0.16129032258064516	36159840
CD274	IL22	0.2980364656381486	36159840
CD274	IL4	0.16129032258064516	36159840
CD274	IL6	0.2980364656381486	36159840
CD274	LIF	0.16129032258064516	36159840
CD274	MIR15B	0.16129032258064516	33462141
CD274	NRF1	0.16129032258064516	33462141
CD274	PDCD1	1.555727321934218e-07	36159840
CD274	PDCD1	1.555727321934218e-07	34992611
CD274	PDCD1	1.555727321934218e-07	32702598
CD274	PDCD1	1.555727321934218e-07	33555016
CD274	PDCD1	1.555727321934218e-07	33173388
CD274	PDCD1	1.555727321934218e-07	33462141
CD274	PDCD1	1.555727321934218e-07	34158318
CD274	PDCD1	1.555727321934218e-07	32960847
CD274	PDCD1	1.555727321934218e-07	32298485
CD274	PDCD1	1.555727321934218e-07	35917654
CD274	PDCD1	1.555727321934218e-07	32540858
CD274	PDCD1	1.555727321934218e-07	33314269
CD274	PDCD1	1.555727321934218e-07	35432346
CD274	SNCA	0.41374474053295934	32934876
CD28	CSF2	0.010752688172043012	36159840
CD28	HAVCR2	0.010752688172043012	36159840
CD28	IL15	0.010752688172043012	36159840
CD28	IL17C	0.010752688172043012	36159840
CD28	IL21	0.010752688172043012	36159840
CD28	IL22	0.021505376344086023	36159840
CD28	IL4	0.010752688172043012	36159840
CD28	IL6	0.021505376344086023	36159840
CD28	LIF	0.010752688172043012	36159840
CD28	PDCD1	0.2688172043010753	36159840
CD4	CD68	0.00023375409069658717	33555016
CD4	CD68	0.00023375409069658717	34338882
CD4	CD8A	0.0023375409069658717	33555016
CD4	CD8A	0.0023375409069658717	34338882
CD4	CTLA4	0.24263674614305747	33555016
CD4	PDCD1	0.4675081813931744	33555016
CD68	CD8A	0.0023375409069658717	33555016
CD68	CD8A	0.0023375409069658717	34338882
CD68	CTLA4	0.24263674614305747	33555016
antineoplastic agents immunological/adverse effects	anti-bacterial agents/pharmacology	0.07526881720430108	34162429
CD68	PDCD1	0.4675081813931744	33555016
antineoplastic agents immunological/adverse effects	CD274	0.7211307358281716	32702598
CD8A	CTLA4	0.12285259534577969	33555016
CD8A	CTLA4	0.12285259534577969	34147519
antineoplastic agents immunological/adverse effects	CTLA4	0.2218711231553488	32567084
antineoplastic agents immunological/adverse effects	CTLA4	0.2218711231553488	32702598
CD8A	IL17A	0.10518934081346423	33462141
CD8A	MIR15B	0.05376344086021506	33462141
CD8A	MTOR	0.05376344086021506	34987517
antineoplastic agents immunological/adverse effects	PDCD1	0.6088320464631765	32567084
antineoplastic agents immunological/adverse effects	PDCD1	0.6088320464631765	32702598
CD8A	NRF1	0.05376344086021506	33462141
antineoplastic agents immunological/adverse effects	SNCA	0.2113496601575143	33476895
CD8A	PDCD1	0.017573743561420264	33555016
CD8A	PDCD1	0.017573743561420264	34147519
CD8A	PDCD1	0.017573743561420264	34987517
CD8A	PDCD1	0.017573743561420264	33462141
CHI3L1	CXCL8	0.010752688172043012	36096534
CHI3L1	IL17A	0.021505376344086023	36096534
CHI3L1	IL6	0.021505376344086023	36096534
CSF2	HAVCR2	0.010752688172043012	36159840
CSF2	IL15	0.010752688172043012	36159840
CSF2	IL17C	0.010752688172043012	36159840
CSF2	IL21	0.010752688172043012	36159840
CSF2	IL22	0.021505376344086023	36159840
CSF2	IL4	0.010752688172043012	36159840
CSF2	IL6	0.021505376344086023	36159840
CSF2	LIF	0.010752688172043012	36159840
CSF2	PDCD1	0.2688172043010753	36159840
CTLA4	CXCL10	0.12903225806451613	35977003
CTLA4	CXCL9	0.12903225806451613	35977003
CTLA4	PDCD1	7.400826146728449e-07	34992611
CTLA4	PDCD1	7.400826146728449e-07	32702598
CTLA4	PDCD1	7.400826146728449e-07	32603654
CTLA4	PDCD1	7.400826146728449e-07	33555016
CTLA4	PDCD1	7.400826146728449e-07	35977003
CTLA4	PDCD1	7.400826146728449e-07	32567084
CTLA4	PDCD1	7.400826146728449e-07	35917654
CTLA4	PDCD1	7.400826146728449e-07	35191192
CTLA4	PDCD1	7.400826146728449e-07	35432346
CTLA4	PDCD1	7.400826146728449e-07	33314269
CTLA4	PDCD1	7.400826146728449e-07	34147519
CTLA4	SNCA	0.34250882357474227	32934876
CTLA4	TCIM	0.12903225806451613	35977003
CTLA4	TNF	0.34250882357474227	35977003
CXCL10	CXCL9	0.010752688172043012	35977003
CXCL10	PDCD1	0.2688172043010753	35977003
CXCL10	TCIM	0.010752688172043012	35977003
CXCL10	TNF	0.03225806451612904	35977003
CXCL8	IL17A	0.021505376344086023	36096534
CXCL8	IL6	0.021505376344086023	36096534
CXCL9	PDCD1	0.2688172043010753	35977003
CXCL9	TCIM	0.010752688172043012	35977003
CXCL9	TNF	0.03225806451612904	35977003
HAVCR2	IL15	0.010752688172043012	36159840
HAVCR2	IL17C	0.010752688172043012	36159840
HAVCR2	IL21	0.010752688172043012	36159840
HAVCR2	IL22	0.021505376344086023	36159840
HAVCR2	IL4	0.010752688172043012	36159840
HAVCR2	IL6	0.021505376344086023	36159840
HAVCR2	LIF	0.010752688172043012	36159840
HAVCR2	PDCD1	0.2688172043010753	36159840
IL15	IL17C	0.010752688172043012	36159840
IL15	IL21	0.010752688172043012	36159840
IL15	IL22	0.021505376344086023	36159840
IL15	IL4	0.010752688172043012	36159840
IL15	IL6	0.021505376344086023	36159840
IL15	LIF	0.010752688172043012	36159840
IL15	PDCD1	0.2688172043010753	36159840
IL17A	IL6	0.04277699859747545	36096534
IL17A	MIR15B	0.021505376344086023	33462141
IL17A	NRF1	0.021505376344086023	33462141
IL17A	PDCD1	0.4675081813931744	33462141
IL17C	IL21	0.010752688172043012	36159840
IL17C	IL22	0.021505376344086023	36159840
IL17C	IL4	0.010752688172043012	36159840
IL17C	IL6	0.021505376344086023	36159840
IL17C	LIF	0.010752688172043012	36159840
IL17C	PDCD1	0.2688172043010753	36159840
IL21	IL22	0.021505376344086023	36159840
IL21	IL4	0.010752688172043012	36159840
IL21	IL6	0.021505376344086023	36159840
IL21	LIF	0.010752688172043012	36159840
IL21	PDCD1	0.2688172043010753	36159840
IL22	IL4	0.021505376344086023	36159840
IL22	IL6	0.04277699859747545	36159840
IL22	LIF	0.021505376344086023	36159840
IL22	PDCD1	0.4675081813931744	36159840
IL4	IL6	0.021505376344086023	36159840
IL4	LIF	0.010752688172043012	36159840
IL4	PDCD1	0.2688172043010753	36159840
IL6	LIF	0.021505376344086023	36159840
IL6	PDCD1	0.4675081813931744	36159840
LIF	PDCD1	0.2688172043010753	36159840
MIR15B	NRF1	0.010752688172043012	33462141
MIR15B	PDCD1	0.2688172043010753	33462141
MTOR	PDCD1	0.2688172043010753	34987517
NRF1	PDCD1	0.2688172043010753	33462141
PARP1	PDCD1	0.2688172043010753	33495297
PARP1	TIPARP	0.010752688172043012	33495297
PDCD1	TCIM	0.2688172043010753	35977003
PDCD1	TIPARP	0.2688172043010753	33495297
PDCD1	TNF	0.613797142548896	35977003
SNCA	TNF	0.09467811291093199	32641348
TCIM	TNF	0.03225806451612904	35977003
